EOS Med Chem Impurity Stock 20201029-15

   

EOS Med Chem is serving more than 100 Pharma companies, we have the original Drug Discovery Compounds, Like Impurity, small molecule and inhibitor.

Impurity we keep stock more than 80000, most in stock, we are World Sole Original Supplier, Each impurity we could supply: Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA.

EOS Med Chem Quotation include: Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, COA, MSDS.

Welcome to visit: our youtube:  https://youtu.be/r5cJdXKNXHk 

Contact:

EOS Med Chem, Medicinal Chemical is Big

執大象，天下往，往而無害，安平泰

Ms Nina

Youtube: https://youtu.be/r5cJdXKNXHk 

E: info@eosmedchem.com 

W: www.eosmedchem.com 

Tel: 0086-531-69905422

SALE OFFICE: 16F, China Overseas Plaza, Jinan City, China

Pyrazine-2,5-dicarboxylic Acid, CAS: 122-05-4, stock: 1.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄N₂O₄.

Pyrazine-2,6-diamine Hydrochloride, CAS: 1370411-48-5, stock: 4.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₆N₄ • HCl.

Pyrazine-2-carbaldehyde, CAS: 5780-66-5, stock: 8.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄N₂O.

Pyrazine-2-carbohydrazide, CAS: 768-05-8, stock: 9.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆N₄O.

Pyrazine-2-carbothioamide, CAS: 4604-72-2, stock: 8.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅N₃S.

Pyrazine-2-N-cyanoamidine, CAS: 1053656-81-7, stock: 7.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅N₅.

Pyrazine-2-sulfonamide, CAS: 1195533-51-7, stock: 4.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₅N₃O₂S.

Pyrazinecarboxylic Acid, CAS: 98-97-5, stock: 1.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄N₂O₂.

Pyrazinecarboxylic Acid-d3, CAS: 1794791-32-4, stock: 6.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅HD₃N₂O₂.

Pyrazinenitrile, CAS: 19847-12-2, stock: 7.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₃N₃.

Pyrazinoic Acid Ethyl Ester, CAS: 6924-68-1, stock: 7.9g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈N₂O₂.

Pyrazinoic Acid-d3 Ethyl Ester, CAS: 1246815-81-5, stock: 5.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅D₃N₂O₂.

Pyrazino[2,3-f][4,7]phenanthroline, CAS: 217-82-3, stock: 2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₈N₄.

rac-Sitagliptin, CAS: 823817-56-7, stock: 4.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅F₆N₅O.

rac-Sitagliptin-d4 Hydrochloride, CAS: 1620233-77-3, stock: 2.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₁D₄F₆N₅O  • HCl.

Ranirestat, CAS: 147254-64-6, stock: 7.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₁BrFN₃O₄.

S-Phenyl Pyrazine-2-carbothioate, CAS: 121761-15-7, stock: 3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₈N₂OS.

Savolitinib, CAS: 1313725-88-0, stock: 6.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₅N₉.

Saxagliptin Cyclic Amide, CAS: 1350800-77-9, stock: 7.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₄N₂O₃.

SC 144 Hydrochloride, CAS: 917497-70-2, stock: 7.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₁FN₆O • HCl.

SC144, CAS: 895158-95-9, stock: 4.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₁FN₆O.

SHA 68, CAS: 847553-89-3, stock: 5.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₄FN₃O₃.

Sitagliptin Maleate Adduct (mixture of diastereomers), CAS: /, stock: 8.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₉F₆N₅O₅.

Sitagliptin Phosphate, CAS: 654671-78-0, stock: 8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈F₆N₅O₅P.

Sitagliptin Phosphate Monohydrate, CAS: 654671-77-9, stock: 3.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅F₆N₅O•H₃O₄P•H₂O.

Sitagliptin-d4 Hydrochloride, CAS: /, stock: 8.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₁D₄F₆N₅O • HCl.

Sitagliptin-d4 Phosphate, CAS: 1432063-88-1, stock: 8.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄D₄F₆N₅O₅P.

Sulfachloropyrazine, CAS: 102-65-8, stock: 3.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉ClN₄O₂S.

Sulfachloropyrazine Sodium Monohydrate, CAS: 1392129-96-2, stock: 8.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀ClN₄NaO₃S.

Sulfachloropyrazine-d4, CAS: /, stock: 7.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₅D₄ClN₄O₂S.

Sulfamethoxypyrazine, CAS: 152-47-6, stock: 1.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂N₄O₃S.

Sulfaquinoxaline, CAS: 59-40-5, stock: 3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂N₄O₂S.

Sulfaquinoxaline-d4, CAS: 1329652-02-9, stock: 5.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₈D₄N₄O₂S.

T-3256336, CAS: 1266227-69-3, stock: 4.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₄₅F₂N₅O₅.

T-3256336-d3, CAS: /, stock: 7.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₄₂D₃F₂N₅O₅.

T-705 Ribofuranose, CAS: 356782-88-2, stock: 4.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂FN₃O₆.

T-705 Ribofuranose-13C5, CAS: /, stock: 2.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³C₅H₁₂FN₃O₆.

T-705RMP, CAS: 356783-08-9, stock: 7.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃FN₃O₉P.

T-705RMP-13C5, CAS: /, stock: 8.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³C₅H₁₃FN₃O₉P.

T-705RTP-13C5 Sodium Salt, CAS: /, stock: 8.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³C₅H₁₅FN₃O₁₅P₃ . Naₓ.

TC-E 5005, CAS: 959705-64-7, stock: 5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈N₄O.

tert-Butyl (2-Bromothiazol-5-yl)carbamate, CAS: 1094070-77-5, stock: 9.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁N₂O₂SBr.

tert-Butyl (7R,8aS)-7-Hydroxy-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazine-2-carboxylate, CAS: 1204603-42-8, stock: 7.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂N₂O₃.

tert-Butyl 1-Bromo-5,6-dihydroimidazo[1,5-a]pyrazine-7(8H)-carboxylate, CAS: 1188265-64-6, stock: 8.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆BrN₃O₂.

tert-Butyl 1-Methyl-6-(methylcarbamoyl)-1H,2H,3H,4H-pyrrolo[1,2-a]pyrazine-2-carboxylate, CAS: 1087784-18-6, stock: 4.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₃N₃O₃.

tert-Butyl 2-Amino-6,7-dihydropyrazolo[1,5-a]pyrazine-5(4H)-carboxylate, CAS: 1209487-56-8, stock: 6.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₈N₄O₂.

tert-Butyl 3,4-Dihydropyrrolo[1,2-a]pyrazine-2(1H)-carboxylate, CAS: 1174068-78-0, stock: 3.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈N₂O₂.

tert-Butyl 3-(Trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-carboxylate, CAS: 877402-43-2, stock: 3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅F₃N₄O₂.

tert-Butyl 3-Bromo-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-carboxylate, CAS: 723286-80-4, stock: 9.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅N₄O₂Br.

tert-Butyl 3-Bromo-5,6-dihydroimidazo[1,5-a]pyrazine-7(8H)-carboxylate, CAS: 1188264-74-5, stock: 6.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₃O₂Br.

tert-Butyl 4-(2-Formyl-4-nitrophenyl)tetrahydro-1(2H)-pyrazinecarboxylate, CAS: 1017782-93-2, stock: 10g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₁N₃O₅.

tert-Butyl 4-(3-Methoxy-4-nitrophenyl)tetrahydro-1(2H)-pyrazinecarboxylate, CAS: 1017782-79-4, stock: 9.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₃N₃O₅.

tert-Butyl 4-[(5-Bromo-2-thienyl)carbonyl]tetrahydro-1(2H)-pyrazinecarboxylate, CAS: 1017782-71-6, stock: 2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉BrN₂O₃S.

tert-Butyl 4-[(5-Bromo-3-pyridinyl)carbonyl]tetrahydro-1(2H)-pyrazinecarboxylate, CAS: 1017782-72-7, stock: 6.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₀BrN₃O₃.

tert-Butyl 4-[2-(3-Nitrophenoxy)ethyl]tetrahydro-1(2H)-pyrazinecarboxylate, CAS: 1135283-71-4, stock: 2.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₅N₃O₅.

tert-Butyl 4-[5-Bromo-3-(methoxycarbonyl)-2-pyridinyl]tetrahydro-1(2H)-pyrazinecarboxylate, CAS: 1000018-22-3, stock: 3.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₂N₃O₄Br.

tert-Butyl 5,6-Dihydroimidazo[1,5-a]pyrazine-7(8H)-carboxylate, CAS: 374795-76-3, stock: 4.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₇N₃O₂.

tert-Butyl 5-amino-1,2,3,6-tetrahydropyrazine-1-carboxylate Dihydrochloride, CAS: 1795355-98-4, stock: 5.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₇N₃O₂ • 2 (HCl).

tert-Butyl 6-Formyl-3,4-dihydropyrrolo[1,2-a]pyrazine-2(1H)-carboxylate, CAS: 1174068-79-1, stock: 9.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈N₂O₃.

tert-Butyl 8-Oxo-3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-carboxylate, CAS: 877402-44-3, stock: 6.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃F₃N₄O₃.

Tetramethylpyrazine, CAS: 1124-11-4, stock: 5.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂N₂.

Trimethyl Bromoorthoacetate, CAS: 40070-40-4, stock: 3.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₁BrO₃.

VE 821, CAS: 1232410-49-9, stock: 8.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₆N₄O₃S.

Vildagliptin Lactam, CAS: /, stock: 7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₄N₂O₃.

Yoda 1, CAS: 448947-81-7, stock: 8.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₈Cl₂N₄S₂.

Zinc Cyanide, CAS: 557-21-1, stock: 3.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂N₂Zn.

[(6-​Methyl-​2-​pyrazinyl)​methyl]​triphenyl-phosphonium Chloride, CAS: 124163-75-3, stock: 9.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₂ClN₂P.

[1,2,4]Triazolo[4,3-a]pyrazine-3-carboxylic Acid, CAS: 1245644-97-6, stock: 5.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄N₄O₂.

[1-(Ethylamino)cyclohexyl]methanol, CAS: 852108-26-0, stock: 2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₉NO.

[2R-(2α,5α,10aβ,10bα)]-Octahydro-10b-hydroxy-2-methyl-3,6,8-trioxo-5-(phenylmethyl)-8H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazine-2-carboxylic Acid Ethyl Ester, CAS: 75323-62-5, stock: 1.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄N₂O₇.

[2R-(2α,5α,10aβ,10bα)]-[Octahydro-10b-hydroxy-2-(1-methylethyl)-5-(2-methylpropyl)-3,6-dioxo-8H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl]-carbamic Acid, CAS: 24177-09-1, stock: 9.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₃N₃O₆.

(1R,2R)-2-Amino-1-[4-(methylsulfonyl)phenyl]-1,3-propanediol Hydrochloride, CAS: 56724-21-1, stock: 6.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆ClNO₄S.

(1S,2R)-2-Amino-1-phenyl-1,3-propanediol-13C6 Hydrochloride, CAS: /, stock: 8.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃¹³C₆H₁₄ClNO₂.

(1S,2S)-(+)-2-Amino-1-phenyl-1,3-propanediol, CAS: 28143-91-1, stock: 8.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃NO₂.

(2-Ethoxycarbonyl)phenylboronic acid, propanediol cyclic ester, CAS: 850567-60-1, stock: 3.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅BO₄.

(2R)-2-Isopropyl-2-(benzyloxy)-propanedioic Acid 1-Ethyl Ester (1S,2S)-2-Amino-1-(4-nitrophenyl)-1,3-propanediol Salt, CAS: 86195-29-1, stock: 8.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₂N₂O₉.

(2R)-3-(2-Chloro-4-nitro-1H-imidazol-1-yl)-2-methyl-1,2-propanediol, CAS: 681490-91-5, stock: 6.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₀ClN₃O₄.

(2RS,3RS)-3-(2-Ethoxy-d5-phenoxy)-1,2-dihydroxy-3-phenylpropane, CAS: 1276340-65-8, stock: 1.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₅D₅O₇.

(2RS,3RS)-3-(2-Ethoxyphenoxy)-1,2-dihydroxy-3-phenylpropane, CAS: 98769-69-8, stock: 6.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀O₄.

(2RS,3RS)-3-(2-Ethoxyphenoxy)-2-hydroxy-1-(4-nitrobenzoyloxy)-3-phenylpropane, CAS: 98769-70-1, stock: 3.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₃NO₇.

(R)-(-)-3-Chloro-1,2-propanediol, CAS: 57090-45-6, stock: 5.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₇ClO₂.

(R)-2-Benzyl-3-hydroxypropyl Acetate, CAS: 110270-49-0, stock: 4.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆O₃.

(R)-3-Amino-1,2-propanediol, CAS: 66211-46-9, stock: 9.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₉NO₂.

(R)-3-Isopropylamino-1,2-propanediol, CAS: 97988-45-9, stock: 3.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₅NO₂.

(R)-4-Chloromethyl-2,2-dimethyl-1,3-dioxolane, CAS: 57044-24-3, stock: 1.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁ClO₂.

(R)-Methocarbamol, CAS: 145841-69-6, stock: 2.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅NO₅.

(S)-1-tert-Butylamino-2,3-propanediol, CAS: 30315-46-9, stock: 4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₇NO₂.

(S)-2-Benzyl-3-hydroxypropyl Acetate, CAS: 110270-52-5, stock: 7.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆O₃.

(S)-3-Amino-1,2-propanediol, CAS: 61278-21-5, stock: 3.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₉NO₂.

(S)-3-Chloro-1,2-propanediol, CAS: 60827-45-4, stock: 9.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₇ClO₂.

(S)-3-Isopropylamino-1,2-propanediol, CAS: 90742-94-2, stock: 8.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₅NO₂.

(S)-4-Chloromethyl-2,2-dimethyl-1,3-dioxolane, CAS: 60456-22-6, stock: 8.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁ClO₂.

(S)-Methocarbamol, CAS: 108914-10-9, stock: 3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅NO₅.

(Z)-2-Chloropropane-1,3-diyl Dioleate, CAS: 1639207-42-3, stock: 6.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₇₁ClO₄.

(Z)-2-Chloropropane-1,3-diyl Dioleate-d5, CAS: /, stock: 8.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₆₆D₅ClO₄.

1,1-Bis(hydroxymethyl)cyclopropane, CAS: 39590-81-3, stock: 3.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀O₂.

1,3,2-Dioxathiane 2,2-Dioxide, CAS: 1073-05-8, stock: 4.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₆O₄S.

1,3-Bis(O-dimethoxytrityl)-2-(N-Fmoc-4-aminobutyl)-1,3-propanediol, CAS: 353754-96-8, stock: 1.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₄H₆₃NO₈.

1,3-Dilinoleoyl-2-chloropropanediol, CAS: 1432592-04-5, stock: 7.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₆₇ClO₄.

1,3-Dioleoyl-2-chloropropanediol-d5, CAS: /, stock: 5.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₆₆D₅ClO₄.

1,3-Dioxane-13C4, CAS: /, stock: 6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₄H₈O₂.

1,3-Distearoyl-2-chloropropanediol, CAS: 26787-56-4, stock: 8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₇₅ClO₄.

1,3-Distearoyl-2-chloropropanediol-18O2, CAS: /, stock: 6.6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₇₅ClO₂¹⁸O₂.

1,3-Distearoyl-2-chloropropanediol-d5, CAS: 1329796-49-7, stock: 6.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₇₀D₅ClO₄.

1,3-Distearoyl-2-chloropropanediol-d5 (Major), CAS: 1329796-49-7, stock: 1.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₇₀D₅ClO₄.

1,3-Propanediol Di-p-toluenesulfonate, CAS: 5469-66-9, stock: 1.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀O₆S₂.

1,3-Propanediol-d8, CAS: 285978-25-8, stock: 3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃D₈O₂.

1-(Piperidin-4-yl)Propane-1,3-diol, CAS: 848070-11-1, stock: 7.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₇NO₂.

1-Decanoyl-2-lauroyl-3-chloropropanediol-13C3, CAS: /, stock: 8.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂¹³C₃H₄₇ClO₄.

1-Decanoyl-2-lauroyl-3-chloropropanediol-d5, CAS: /, stock: 3.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₄₂D₅ClO₄.

1-Decanoyl-2-octanoyl-3-chloropropanediol-13C3, CAS: /, stock: 7.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈¹³C₃H₃₉ClO₄.

1-Decanoyl-2-octanoyl-3-chloropropanediol-d5, CAS: /, stock: 4.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₄D₅ClO₄.

1-Descarbamoyl-2-carbamoyl Methocarbamol, CAS: 10488-39-8, stock: 8.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅NO₅.

1-Descarbamoyl-2-carbamoyl Methocarbamol-d5, CAS: 1794780-30-5, stock: 4.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀D₅NO₅.

1-O-Dimethoxytrityl-2-(N-Fmoc)-4-Aminobutyl)-1,3-propanediol, 90%, CAS: 147190-32-7, stock: 5.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₃H₄₅NO₆.

1-Octanoyl-2-decanoyl-3-chloropropanediol-13C3, CAS: /, stock: 7.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈¹³C₃H₃₉ClO₄.

1-Octanoyl-2-decanoyl-3-chloropropanediol-d5, CAS: /, stock: 8.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₄D₅ClO₄.

1’,2’-Dehydro Meprobamate, CAS: 25462-39-9, stock: 5.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₆N₂O₄.

2,2-Di-N-octyl-1,3-propanediol, CAS: 106868-09-1, stock: 5.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₄₀O₂.

2,2-Diisoamyl-1,3-propanediol, CAS: 403519-64-2, stock: 9.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₈O₂.

2,2-Dimethoxy-1,3-propanediol 1-(Dihydrogen Phosphate) Barium Salt, CAS: /, stock: 2.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₁BaO₇P.

2,2’-Imino-bis-[1,3-bis-O-(1,6-anhydro-2,3-O-iospropylidene-β-D-mannopyranose)-1,3-propanediol], CAS: /, stock: 2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₆₃NO₂₀.

2,3-Bis(4-chlorophenyl)-2,3-butanediol, CAS: /, stock: 5.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆Cl₂O₂.

2,4-Difluorophenylboronic acid, propanediol cyclic ester, CAS: 1073372-07-2, stock: 9.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉BF₂O₂.

2-(2-Propen-1-yl)-1,3-propanediol, CAS: 42201-43-4, stock: 2.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂O₂.

2-(Acetoxymethoxy)-1,3-propanediyl Dibenzoate, CAS: 110874-22-1, stock: 8.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₀O₇.

2-(Acetoxymethoxy)-1,3-propanediyl-d5 Dibenzoate, CAS: 1185159-39-0, stock: 9.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₅D₅O₇.

2-(Ethylamino)-2-[2-(4-octylphenyl)ethyl]-1,3-propanediol Hydrochloride, CAS: 1402702-70-8, stock: 4.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₇NO₂ • H Ci.

2-(Ethylamino)-2-[2-(4-octylphenyl)ethyl]-1,3-propanediol-d4 Hydrochloride, CAS: /, stock: 3.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₃D₄NO₂ • H Ci.

2-(Methoxymethoxy)-1,3-propanediyl Dibenzoate, CAS: 110874-21-0, stock: 5.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₀O₆.

2-(Methoxymethoxy)-1,3-propanediyl Dibenzoate-d5, CAS: 1346601-25-9, stock: 3.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₅D₅O₆.

2-(N,N-Dibenzyl)-amino-1,3-propanediol, CAS: 246232-73-5, stock: 6.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₁NO₂.

2-(N-Fmoc-4-aminobutyl)-1,3-propanediol, CAS: 147190-31-6, stock: 9.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₇NO₄.

2-Allyl-2-methyl-1,3-propanediol, CAS: 25462-37-7, stock: 1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₄O₂.

2-Amino-1-phenyl-1,3-propanediol, CAS: 55057-81-3, stock: 9.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃NO₂.

2-Benzyl-1,3-propanediol, CAS: 2612-30-8, stock: 6.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄O₂.

2-Benzyl-1,3-propanediol Diacetate, CAS: 110230-64-3, stock: 1.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈O₄.

2-Bromo-1,3-bis(tert-butyldimethylsilyloxy)propane-d4, CAS: 1794816-65-1, stock: 5.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₃₁D₄BrO₂Si₂.

2-Chloro-3-[(1-oxohexadecyl)oxy]propyl octadecanoate, CAS: 1639207-44-5, stock: 5.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₇₁ClO₄.

2-Chloro-3-[(1-oxooctadecyl)oxy]propyl (9Z)-9-octadecenoate, CAS: 1639207-45-6, stock: 9.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₇₃ClO₄.

2-Chloro-3-[(1-oxooctadecyl)oxy]propyl (9Z,12Z)-9,12-octadecadienoate, CAS: 1639207-43-4, stock: 2.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₇₁ClO₄.

2-Chloro-5,5-dimethyl-1,3,2-dioxaphosphorinane 2-oxide, CAS: 4090-55-5, stock: 3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀ClO₃P.

2-Ethyl-2-methyl-1,3-propanediol, CAS: 77-84-9, stock: 5.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₄O₂.

2-Methyl-3-(2’,3’-dihydroxypropyl)quinoxaline, CAS: 42015-36-1, stock: 7.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄N₂O₂.

2-Methylbenzeneboronic Acid Propanediol Cyclic Ester, CAS: 163517-56-4, stock: 9.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃BO₂.

2-Methylene-1,3-propanediol, CAS: 3513-81-3, stock: 8.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₈O₂.

2-[(3-Methoxyphenyl)methyl]-1,3-propanediol, CAS: 77756-13-9, stock: 3.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆O₃.

2-[(3-Methoxyphenyl)methyl]-1,3-propanediol 1-Acetate, CAS: 1391053-85-2, stock: 2.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈O₄.

3-(1-Naphthalenyloxy)-1,2-propanediol, CAS: 36112-95-5, stock: 5.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄O₃.

3-(1-Naphthalenyloxy)-1,2-propanediol-d5, CAS: 69533-57-9, stock: 9.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₉D₅O₃.

3-(1H-Indol-4-yloxy)-1,2-propanediol, CAS: 61212-32-6, stock: 8.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃NO₃.

3-(Dimethylamino)-1,2-propanediol, CAS: 623-57-4, stock: 4.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₃NO₂.

3-(Phenylmethoxy)-1,2-propanediol 1,2-Diacetate, CAS: 151121-12-9, stock: 9.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈O₅.

3-Methylamino-1,2-propanediol, CAS: 40137-22-2, stock: 7.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₁NO₂.

3-Morpholino-1,2-propanediol, CAS: 6425-32-7, stock: 8.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₅NO₃.

3-Phenoxy-1,2-propanediol, CAS: 538-43-2, stock: 9.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂O₃.

3-[(Prop-2-en-1-yl)amino]propane-1,2-diol, CAS: 13348-89-5, stock: 4.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO₂.

3-[(Prop-2-en-1-yl)amino]propane-1,2-diol-d5, CAS: /, stock: 7.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈D₅NO₂.

3-[1-(2,4-Dichlorophenyl)-2-(1H-imidazol-1-yl)ethoxy]-1,2-propanediol(Mixture of Diastereomers), CAS: 86491-83-0, stock: 3.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆Cl₂N₂O₃.

3-[4-(2-Methoxyethyl)phenoxy]-1,2-propanediol, CAS: 62572-90-1, stock: 8.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈O₄.

3-[4-(2-Methoxyethyl)phenoxy]-1,2-propanediol-d5, CAS: 1246815-20-2, stock: 1.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃D₅O₄.

3-[4-[1-[4-(3-Chloro-2-hydroxypropoxy)phenyl]-1-methylethyl]phenoxy]-1,2-propanediol, CAS: 227947-06-0, stock: 3.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₇ClO₅.

4,4-Dimethyl-1,3-dioxolan-2-one, CAS: 4437-69-8, stock: 9.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₈O₃.

6-Amino-2-hydroxymethyl Hexan-1-ol, CAS: 125162-81-4, stock: 1.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₇NO₂.

9-(4-Acetoxy-3-acetoxymethylbutyl)-2-amino-6-chloropurine-d4, CAS: 1020718-81-3, stock: 9.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₄D₄ClN₅O₄.

Adenosine 3’,5’-cyclic Monophosphate Tris Salt, CAS: 102029-77-6, stock: 9.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₅O₆P • ( C₄H₁₁NO₃).

Antiblaze V6, CAS: 38051-10-4, stock: 7.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₄Cl₆O₈P₂.

Antiblaze V6-d16, CAS: /, stock: 9.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₈D₁₆Cl₆O₈P₂.

Bronopol, CAS: 52-51-7, stock: 1.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₆BrNO₄.

Carboprost Tromethamine, CAS: 58551-69-2, stock: 5.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₄₇NO₈.

D,L-Dropropizine N,N-Dioxide, CAS: 152237-41-7, stock: 4.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₀N₂O₄.

D,L-Dropropizine N-Oxide, CAS: 152323-00-7, stock: 3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₀N₂O₃.

Dapagliflozin Propanediol Hydrate, CAS: 960404-48-2, stock: 9.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅ClO₆ •  C₃H₈O₂ • H ₂O.

Diperodon Hydrochloride, CAS: 537-12-2, stock: 6.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₇N₃O₄ •HCl.

L-(+)-Threo-2-(N,N-dimethylamino)-1-(4-aminophenyl)-1,3-propanediol, CAS: 129170-43-0, stock: 1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₈N₂O₂.

L-(+)-threo-2-Amino-1-(4-aminophenyl)-1,3-propanediol, CAS: 50961-68-7, stock: 8.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄N₂O₂.

L-threo-(+)-2-Amino-1-(4-nitrophenyl)-1,3-propanediol, CAS: 2964-48-9, stock: 6.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂O₄.

Menthoxypropane-1,2-diol, CAS: 87061-04-9, stock: 6.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₆O₃.

Methocarbamol-d3, CAS: 1346600-86-9, stock: 6g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂D₃NO₅.

Methocarbamol-d5, CAS: 1189699-70-4, stock: 7.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀D₅NO₅.

Methocarbamol-O-sulfate Sodium Salt, CAS: 1329610-40-3, stock: 3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄NNaO₈S.

Methocarbamol-O-sulfate-d5 Sodium Salt, CAS: 1330055-80-5, stock: 8.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉D₅NNaO₈S.

N-(1-Hydroxy-2-(hydroxymethyl)-4-(4-octylphenyl)butan-2-yl)acetamide, CAS: 249289-10-9, stock: 9.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₅NO₃.

NPG Glycol, CAS: 126-30-7, stock: 4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₂O₂.

Osmium Tetroxide, CAS: 20816-12-0, stock: 4.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  O₄Os.

(2E)-Dehydro Propafenone Hydrochloride, CAS: /, stock: 2.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₆ClNO₃.

(2E)-Dehydro Propafenone-d5 Hydrochloride, CAS: 1331643-41-4, stock: 3.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁D₅ClNO₃.

Phenaglycodol, CAS: 79-93-6, stock: 5.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅ClO₂.

(R)-5-Hydroxy Propafenone Hydrochloride, CAS: 158080-72-9, stock: 3.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₈ClNO₄.

Phenaglycodol-2,3-O-TMS, CAS: /, stock: 9.5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₃₁ClO₂Si₂.

Propylene Carbonate, CAS: 108-32-7, stock: 8.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₆O₃.

(R)-Propafenone, CAS: 107381-31-7, stock: 3.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₇NO₃.

(S)-1-(2-(oxiran-2-ylmethoxy)phenyl)-3-phenylpropan-1-one, CAS: /, stock: 8.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈O₃.

Propylene Glycol Dilaurate, CAS: 22788-19-8, stock: 8.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₅₂O₄.

Prostaglandin F2α Tromethamine Salt, CAS: 38562-01-5, stock: 2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₄₅NO₈.

(S)-5-Hydroxy Propafenone Hydrochloride, CAS: 158080-71-8, stock: 2.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₈ClNO₄.

(S)-Propafenone, CAS: 107381-32-8, stock: 9.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₇NO₃.

1,1’-[Hydroxypropane-1,3-diylbis(oxy-2,1-phenylene)]bis(3-phenylpropan-1-one), CAS: 1329643-40-4, stock: 4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₂O₅.

1,1’-[Hydroxypropane-1,3-diylbis(oxy-2,1-phenylene)]bis(3-phenylpropan-1-one)-d5, CAS: 1330053-58-1, stock: 8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₂₇D₅O₅.

1-(5-(Benzyloxy)-2-(oxiran-2-ylmethoxy)phenyl)-3-phenyl-d5-propan-1-one, CAS: /, stock: 7.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₁₉D₅O₄.

1-[2-(Oxiranylmethoxy)-5-(benzyloxy)phenyl]-3-phenyl-2-propen-1-one, CAS: 93885-31-5, stock: 6.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₂O₄.

1-[2-hydroxy-5-(phenylmethoxy)phenyl]-3-phenyl-d5-1-Propanone, CAS: /, stock: 5.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₅D₅O₃.

2-Methyl-1-methylhydroxy Propafenone Hydrochloride, CAS: /, stock: 8.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₂ClNO₄.

2-[2-[(2S)-2-Oxiranylmethoxy]phenyl]-2-(2-phenylethyl)-1,3-dioxolane, CAS: 189766-50-5, stock: 4.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂O₄.

rac 1,2-Dioleoyl-3-chloropropanediol, CAS: 886989-14-6, stock: 3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₇₁ClO₄.

rac 1,2-Dioleoyl-3-chloropropanediol-13C3, CAS: /, stock: 1.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆¹³C₃H₇₁ClO₄.

rac 1,2-Dioleoyl-3-chloropropanediol-13C3, CAS: /, stock: 6.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆¹³C₃H₇₁ClO₄.

2’-Hydroxy-3-phenylpropiophenone, CAS: 3516-95-8, stock: 1.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄O₂.

2’-Hydroxy-3-phenylpropiophenone-d5, CAS: 1346601-26-0, stock: 3.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₉D₅O₂.

4-Hydroxy Propafenone Hydrochloride, CAS: 86383-31-5, stock: 3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₈ClNO₄.

4-Hydroxy Propafenone-d5 Hydrochloride, CAS: 1189863-32-8, stock: 8.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃D₅ClNO₄.

4-Phenyl-1-buten-4-ol, CAS: 936-58-3, stock: 2.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂O.

5-Benzyloxy Propafenone, CAS: 200434-70-4, stock: 6.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₃NO₄.

5-Hydroxy Propafenone Hydrochloride, CAS: 86383-32-6, stock: 6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₈ClNO₄.

5-Hydroxy Propafenone Hydrochloride-d5, CAS: 1188265-48-6, stock: 8.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃D₅ClNO₄.

5-Hydroxy Propafenone β-D-Glucuronide, CAS: /, stock: 2.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₅NO₁₀.

5-Hydroxy Propafenone Sulfate, CAS: 1346598-57-9, stock: 1.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₇NO₇S.

5-Hydroxy Propafenone-d5 Hydrochloride, CAS: 1215370-87-8, stock: 6.2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃D₅ClNO₄.

5-Hydroxy Propafenone-d5 β-D-Glucuronide, CAS: /, stock: 7.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₀D₅NO₁₀.

Depropylamino Chloro Propafenone, CAS: 165279-79-8, stock: 7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₉ClO₃.

Depropylamino Chloro Propafenone-d5, CAS: 1346598-65-9, stock: 4.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₄D₅ClO₃.

Depropylamino Hydroxy Propafenone, CAS: 91401-73-9, stock: 3.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₀O₄.

Depropylamino Hydroxy Propafenone-d5, CAS: 1346598-59-1, stock: 9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₅D₅O₄.

Depropylamino-3-methyl Propafenone, CAS: /, stock: 4.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₂O₃.

rac 1-Linolenoyl-3-chloropropanediol-13C3, CAS: /, stock: 3.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈¹³C₃H₃₅ClO₃.

rac 1-Linoleoyl-2-linolenoyl-3-chloropropanediol, CAS: 1612870-93-5, stock: 1.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₆₅ClO₄.

N-Depropyl N-Benzyl Propafenone, CAS: 178691-47-9, stock: 7.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₇NO₃.

rac 1-Linoleoyl-2-oleoyl-3-chloropropanediol, CAS: 1429655-92-4, stock: 6.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₆₉ClO₄.

rac 1-Linoleoyl-2-oleoyl-3-chloropropanediol-13C3, CAS: /, stock: 5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆¹³C₃H₆₉ClO₄.

N-Depropyl Propafenone-d5 Oxalate Salt, CAS: 1215598-59-6, stock: 7.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₈D₅NO₇.

N-Despropyl Propafenone Hydrochloride, CAS: 1188263-52-6, stock: 4.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₂ClNO₃.

rac 1-Linoleoyl-2-oleoyl-3-chloropropanediol-d5, CAS: /, stock: 1.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₆₄D₅ClO₄.

N-Despropyl Propafenone Oxalate Salt, CAS: 93885-20-2, stock: 3.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃NO₇.

Propafenone, CAS: 54063-53-5, stock: 1.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₇NO₃.

Propafenone Dimer Impurity(Mixture of diastereomers), CAS: 1346603-80-2, stock: 5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₄₅NO₆.

Propafenone Dimer Impurity-d10, CAS: 1346602-27-4, stock: 3.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₃₅D₁₀NO₆.

rac 1-O-Trimethylsilyl 2-Oleoyl-3-chloropropanediol, CAS: /, stock: 4.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₄₇ClO₃Si.

Propafenone Hydrochloride, CAS: 34183-22-7, stock: 8.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₈ClNO₃.

Propafenone Hydrochloride 2-Propen-1-one Impurity, CAS: 1331636-87-3, stock: 9.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅NO₃.

rac 1-O-Trimethylsilyl 3-Chloro-propan-2-yl Octadeca-9,12-dienoate, CAS: /, stock: 8.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₄₅ClO₃Si.

Propafenone β-D-Glucuronide, CAS: 91411-76-6, stock: 4.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₅NO₉.

rac 1-Oleoyl-2-chloropropanediol, CAS: 1639207-37-6, stock: 6.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₉ClO₃.

rac 1-Oleoyl-2-chloropropanediol-d5, CAS: /, stock: 2.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₄D₅ClO₃.

Propafenone-d5 Hydrochloride, CAS: 1346605-05-7, stock: 6.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃D₅ClNO₃.

rac 1-Oleoyl-2-linolenoyl-3-chloropropanediol, CAS: /, stock: 6.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₆₇ClO₄.

rac 1-Oleoyl-2-linolenoyl-3-chloropropanediol-13C3, CAS: /, stock: 8.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆¹³C₃H₆₇ClO₄.

Propafenone-d5 Hydrochloride, CAS: 93909-48-9, stock: 9.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃D₅ClNO₃.

Propafenone-d5 Hydrochloride, CAS: 1398066-02-8, stock: 2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃D₅ClNO₃.

rac 1-Oleoyl-2-linolenoyl-3-chloropropanediol-d5, CAS: /, stock: 7.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₆₂D₅ClO₄.

rac 1-Oleoyl-2-linoleoyl-3-chloropropanediol, CAS: 1336935-03-5, stock: 6.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₆₉ClO₄.

Propafenone-d5 β-D-Glucuronide, CAS: /, stock: 1.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₀D₅NO₉.

rac 1-Oleoyl-2-linoleoyl-3-chloropropanediol-13C3, CAS: /, stock: 2.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆¹³C₃H₆₉ClO₄.

rac 1-Oleoyl-2-linoleoyl-3-chloropropanediol-d5, CAS: /, stock: 2.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₆₄D₅ClO₄.

rac 1-Oleoyl-2-stearoyl-3-chloropropanediol, CAS: 1336935-05-7, stock: 3.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₇₃ClO₄.

rac 1-Oleoyl-2-stearoyl-3-chloropropanediol-13C3, CAS: /, stock: 7.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆¹³C₃H₇₃ClO₄.

rac 1-Oleoyl-2-stearoyl-3-chloropropanediol-d5, CAS: /, stock: 1.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₆₈D₅ClO₄.

rac 1-Oleoyl-3-chloropropanediol, CAS: 10311-82-7, stock: 3.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₉ClO₃.

rac 1-Oleoyl-3-chloropropanediol-13C3, CAS: /, stock: 3.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈¹³C₃H₃₉ClO₃.

rac 1-Oleoyl-3-chloropropanediol-d5, CAS: /, stock: 2.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₄D₅ClO₃.

rac 2-Lauroyl-3-chloropropanediol, CAS: 1329647-11-1, stock: 6.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₉ClO₃.

rac 2-Lauroyl-3-chloropropanediol-13C3, CAS: /, stock: 3.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂¹³C₃H₂₉ClO₃.

rac 2-Lauroyl-3-chloropropanediol-d5, CAS: 1330055-73-6, stock: 6.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₄D₅ClO₃.

rac 2-Myristoyl-3-chloropropanediol, 95%, CAS: 1330166-18-1, stock: 2.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₃₃ClO₃.

rac 2-Myristoyl-3-chloropropanediol-13C3, CAS: /, stock: 2.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄¹³C₃H₃₃ClO₃.

rac 2-Myristoyl-3-chloropropanediol-d5, 95%, CAS: 1330056-39-7, stock: 2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₈D₅ClO₃.

rac 2-Oleoyl-3-chloropropanediol-d5, 95%, CAS: 1331669-45-4, stock: 6.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₄D₅ClO₃.

rac 2-Stearoyl-3-chloropropanediol, 95%, CAS: 1329611-08-6, stock: 6.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₄₁ClO₃.

rac 2-Stearoyl-3-chloropropanediol-13C3, CAS: /, stock: 8.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈¹³C₃H₄₁ClO₃.

rac 2-Stearoyl-3-chloropropanediol-d5, 95%, CAS: 1346602-55-8, stock: 5.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₆D₅ClO₃.

rac Dropropizine, CAS: 17692-31-8, stock: 7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₀N₂O₂.

rac Dropropizine-d4 (Major), CAS: /, stock: 8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆D₄N₂O₂.

rac FTY720-d4 Phosphate, CAS: 1794828-93-5, stock: 3.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₀D₄NO₅P.

rac N-(2,3-Dihydroxypropyl)octadecanamide, CAS: 7336-25-6, stock: 3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₄₃NO₃.

rac-1, 2-Didecanoyl-3-chloropropanediol-13C3, CAS: /, stock: 1.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀¹³C₃H₄₃ClO₄.

rac-1, 2-Didecanoyl-3-chloropropanediol-d5, CAS: /, stock: 2.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₈D₅ClO₄.

rac-1,2-Dilinolenoyl-3-chloropropanediol-13C3, CAS: /, stock: 5.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆¹³C₃H₆₃ClO₄.

rac-1,2-Dilinoleoyl-3-chloropropanediol, CAS: 74875-96-0, stock: 4.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₆₇ClO₄.

rac-1,2-Dilinoleoyl-3-chloropropanediol-13C3, CAS: /, stock: 2.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆¹³C₃H₆₇ClO₄.

rac-1,2-Dilinoleoyl-3-chloropropanediol-d5, CAS: /, stock: 7.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₆₂D₅ClO₄.

rac-1,2-Dioctanoyl-3-Chloropropanediol, CAS: 95610-54-1, stock: 5.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₅ClO₄.

rac-1,2-Dioctanoyl-3-Chloropropanediol-13C3, CAS: /, stock: 2.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆¹³C₃H₃₅ClO₄.

rac-1,2-Dioctanoyl-3-Chloropropanediol-d5, CAS: /, stock: 6.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₀D₅ClO₄.

rac-1,2-Distearoyl-3-chloropropanediol, CAS: 72468-92-9, stock: 7.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₇₅ClO₄.

rac-1,2-Distearoyl-3-chloropropanediol-13C3, CAS: /, stock: 9.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆¹³C₃H₇₅ClO₄.

rac-1,2-Distearoyl-3-chloropropanediol-d5, CAS: 1246818-85-8, stock: 6.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₇₀D₅ClO₄.

rac-1,3-Dilinoleoyl-2-chloropropanediol-d5, CAS: /, stock: 1.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₆₂D₅ClO₄.

rac-1-Decanoyl-3-Chloropropanediol-13C3, CAS: /, stock: 5.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀¹³C₃H₂₅ClO₃.

rac-1-Decanoyl-3-Chloropropanediol-d5, CAS: /, stock: 3.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₀D₅ClO₃.

rac-1-Lauroyl-2-decanoyl-3-chloropropanediol-13C3, CAS: /, stock: 3.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂¹³C₃H₄₇ClO₄.

rac-1-Lauroyl-2-decanoyl-3-chloropropanediol-d5, CAS: /, stock: 4.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₄₂D₅ClO₄.

rac-1-Lauroyl-2-stearoyl-3-chloropropanediol-13C3, CAS: /, stock: 5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀¹³C₃H₆₃ClO₄.

rac-1-Lauroyl-2-stearoyl-3-chloropropanediol-d5, CAS: /, stock: 6.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₅₈D₅ClO₄.

rac-1-Linoleoyl-2-chloropropanediol, CAS: 1639207-38-7, stock: 4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₇ClO₃.

rac-1-Linoleoyl-2-chloropropanediol-d5, CAS: /, stock: 1.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₂D₅ClO₃.

rac-1-Linoleoyl-2-linolenoyl-3-chloropropanediol-d5, CAS: /, stock: 5.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₆₀D₅ClO₄.

rac-1-Linoleoyl-2-stearoyl-3-chloropropanediol, CAS: 1246833-46-4, stock: 3.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₇₁ClO₄.

rac-1-Linoleoyl-2-stearoyl-3-chloropropanediol-d5, CAS: /, stock: 4.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₆₆D₅ClO₄.

rac-1-Linoleoyl-3-chloropropanediol, CAS: 74875-98-2, stock: 3.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₇ClO₃.

rac-1-Linoleoyl-3-chloropropanediol-13C3, CAS: /, stock: 4.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈¹³C₃H₃₇ClO₃.

rac-1-Linoleoyl-3-chloropropanediol-d5, CAS: /, stock: 2.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₂D₅ClO₃.

rac-1-Linoleoyl-3-linolenoyl-2-chloropropanediol, CAS: /, stock: 7.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₆₅ClO₄.

rac-1-Linoleoyl-3-linolenoyl-2-chloropropanediol-d5, CAS: /, stock: 9.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₆₀D₅ClO₄.

rac-1-Linoleoyl-3-oleoyl-2-chloropropanediol, CAS: 1639207-40-1, stock: 1.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₆₉ClO₄.

rac-1-Linoleoyl-3-oleoyl-2-chloropropanediol-d5, CAS: /, stock: 3.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₆₄D₅ClO₄.

rac-1-Octanoyl-3-Chloropropanediol-13C3, CAS: /, stock: 8.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³C₃H₁₆ClO₃.

rac-1-Octanoyl-3-Chloropropanediol-d5, CAS: /, stock: 1.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆D₅ClO₃.

rac-1-Palmitoyl-2-linolenoyl-3-chloropropanediol-13C3, CAS: /, stock: 3.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄¹³C₃H₆₅ClO₄.

rac-1-Palmitoyl-2-linoleoyl-3-chloropropanediol, CAS: 1246833-87-3, stock: 2.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₆₇ClO₄.

rac-1-Palmitoyl-2-linoleoyl-3-chloropropanediol-13C3, CAS: /, stock: 3.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄¹³C₃H₆₇ClO₄.

rac-1-Palmitoyl-2-linoleoyl-3-chloropropanediol-d5, CAS: 1246833-66-8, stock: 9.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₆₂D₅ClO₄.

rac-1-Palmitoyl-3-linolenoyl-2-chloropropanediol, CAS: 1639207-39-8, stock: 6.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₆₇ClO₄.

rac-1-Palmitoyl-3-linolenoyl-2-chloropropanediol-d5, CAS: /, stock: 3.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₆₂D₅ClO₄.

rac-1-Palmitoyl-3-oleoyl-2-chloropropanediol, CAS: 1639207-41-2, stock: 8.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₆₉ClO₄.

rac-1-Palmitoyl-3-oleoyl-2-chloropropanediol-d5, CAS: /, stock: 3.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₆₄D₅ClO₄.

rac-1-Stearoyl-3-chloropropanediol, CAS: 22094-20-8, stock: 1.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₄₁ClO₃.

rac-1-Stearoyl-3-chloropropanediol-13C3, CAS: /, stock: 1.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈¹³C₃H₄₁ClO₃.

rac-1-Stearoyl-3-chloropropanediol-d5, CAS: 1795785-84-0, stock: 4.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₆D₅ClO₃.

rac-2-Decanoyl-3-Chloropropanediol-13C3, CAS: /, stock: 9.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀¹³C₃H₂₅ClO₃.

rac-2-Decanoyl-3-Chloropropanediol-d5, CAS: /, stock: 7.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₀D₅ClO₃.

rac-2-Linoleoyl-3-chloropropanediol, 95%, CAS: 1470071-08-9, stock: 2.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₇ClO₃.

rac-2-Linoleoyl-3-chloropropanediol-13C3, CAS: /, stock: 7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈¹³C₃H₃₇ClO₃.

rac-2-Linoleoyl-3-chloropropanediol-d5, 95%, CAS: 1331636-39-5, stock: 9.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₂D₅ClO₃.

rac-2-Octanoyl-3-Chloropropanediol-13C3, CAS: /, stock: 4.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³C₃H₁₆ClO₃.

rac-2-Octanoyl-3-Chloropropanediol-d5, CAS: /, stock: 9.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆D₅ClO₃.

Ro 51, CAS: 1050670-85-3, stock: 8.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₃IN₄O₄.

Tetraoxaspiroundecane-d12, CAS: 1219176-62-1, stock: 2.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇D₁₂O₄.

Trimethylolpropane (1,1,4,4,5-D5) Phosphate, CAS: 85196-38-9, stock: 5.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆D₅O₄P.

Trimethylolpropane Phosphate, CAS: 1005-93-2, stock: 9.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁O₄P.

Tris(hydroxymethyl)undecane, CAS: 4712-32-7, stock: 6.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₃₀O₃.

3,4-Dichloroaniline, CAS: 95-76-1, stock: 1.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅Cl₂N.

Propanil, CAS: 709-98-8, stock: 4.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉Cl₂NO.

Propanil-d5, CAS: 1398065-82-1, stock: 9.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₄D₅Cl₂NO.

Aliquat 336, CAS: 63393-96-4, stock: 4.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  N/A.

(1,2,4-Triazol-4-yl) Posaconazole, CAS: /, stock: 1.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₂F₂N₈O₄.

(2R,4R)-rel-2,4-Bis(2’,4’-difluorophenyl)-2,4-dihydroxypentane, CAS: 1329616-28-5, stock: 4.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆F₄O₂.

(3S,5R)-[(1H-1,2,4-Triazol-1-yl)-methyl-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl]methyl Isobutyrate, CAS: /, stock: 1.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₁F₂N₃O₃.

(5R-cis)-4-[5-(2,4-Difluorophenyl)-5-[1,2,4]triazol-1-ylmethyltetrahydrofuran-3-ylmethyl]methoxy-formanilide, CAS: 357189-97-0, stock: 6.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₀F₂N₄O₃.

(5R-cis)-Toluene-4-sulfonic Acid 5-(2,4-Difluorophenyl)-5-[1,2,4]triazol-1-ylmethyltetrahydrofuran-3-ylmethyl Ester, CAS: 149809-43-8, stock: 7.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁F₂N₃O₄S.

1-(((2R,4R)-4-((Benzyloxy)methyl)-2-(2,4-difluorophenyl)tetrahydrofuran-2-yl)methyl)-1H-1,2,4-triazole, CAS: 165115-83-3, stock: 7.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁F₂N₃O₂.

2,4-Dihydro-2-[(1S,2S)-1-ethyl-2-hydroxypropyl]-4[4-(1-piperazinyl)phenyl]-3H-1,2,4-triazol-3-one, CAS: /, stock: 4.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₅N₅O₂.

2,5-Anhydro-1,3,4-trideoxy-2-C-(2,4-difluorophenyl)-4-[[4-[4-[4-[1-(1-ethylpropyl)-1,5-dihydro-5-oxo-4H-1,2,4-triazol-4-yl]phenyl]-1-piperazinyl]phenoxy]methyl]-1-(1H-1,2,4-triazol-1-yl)-D-threo-pentitol, CAS: 161532-65-6, stock: 8.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₂F₂N₈O₃.

2,​5-​Anhydro-​1,​3,​4-​trideoxy-​2-​C-​(2,​4-​difluorophenyl)​-​4-​(hydroxymethyl)​-​1-​(1H-​1,​2,​4-​triazol-​1-​yl)​-D-​threo-​pentitol, CAS: 160709-02-4, stock: 5.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅F₂N₃O₂.

2-(2,4-Difluorophenyl)-2-propenyl-propanedioic Acid Diethyl Ester, CAS: 159276-62-7, stock: 1.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈F₂O₄.

2-Oxo-posaconazole, CAS: /, stock: 4.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₀F₂N₈O₅.

2-Oxo-posaconazole-d4, CAS: /, stock: 6.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₃₆D₄F₂N₈O₅.

2-[(1S,2S)-1-Ethyl-2-(phenylmethoxy)propyl]-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]-3H-1,2,4-triazol-3-one, CAS: 184177-83-1, stock: 4.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₅N₅O₃.

2-[(1S,2S)-1-Ethyl-2-(phenylmethoxy)propyl]-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]-3H-1,2,4-triazol-3-one-d4, CAS: 1246814-94-7, stock: 1.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₁D₄N₅O₃.

2-[(1S,2S)-1-Ethyl-2-(phenylmethoxy)propyl]-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]-3H-1,2,4-triazol-3-one-d5, CAS: /, stock: 4.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₀D₅N₅O₃.

2-[(1S,2S)-1-Ethyl-2-(phenylmethoxy)propyl]-2,4-dihydro-4-[4-[4-(4-O-methoxymethyl-4-hydroxyphenyl)-1-piperazinyl]phenyl]-3H-1,2,4-triazol-3-one, CAS: 1246815-19-9, stock: 6.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₉N₅O₄.

2-[(1S,2S)-1-Ethyl-2-(phenylmethoxy)propyl]-2,4-dihydro-4-[4-[4-(4-O-methoxymethyl-4-hydroxyphenyl)-1-piperazinyl]phenyl]-3H-1,2,4-triazol-3-one-d4, CAS: 1246815-26-8, stock: 3.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₅D₄N₅O₄.

2-[syn-2-Phenoxy-hex-3-yl]-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]-3H-1,2,4-triazol-3-one, CAS: /, stock: 3.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₅N₅O₃.

3-Oxo-posaconazole (3-​oxo-​1-​piperazinyl), CAS: 357189-94-7, stock: 2.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₀F₂N₈O₅.

4-Desfluoro Posaconazole, CAS: /, stock: 6.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₃FN₈O₄.

4-[4-(4-O-Methoxymethyl-4-hydroxyphenyl)-1-piperazinyl]phenyl]carbamic Acid Phenyl Ester, CAS: 1329503-19-6, stock: 7.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₇N₃O₄.

4-[4-(4-O-Methoxymethyl-4-hydroxyphenyl)-1-piperazinyl]phenyl]carbamic Acid-d4 Phenyl Ester, CAS: 1246817-73-1, stock: 6.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₃D₄N₃O₄.

all-(R)-Posaconazole, CAS: 170985-61-2, stock: 6.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₂F₂N₈O₄.

all-(S)-Posaconazole, CAS: 1246391-73-0, stock: 4.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₂F₂N₈O₄.

Benzyl (4-(4-(4-Hydroxyphenyl)piperazin-1-yl)phenyl)carbamate, CAS: 864685-20-1, stock: 2.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₅N₃O₃.

Desethylene Posaconazole, CAS: 1370190-94-5, stock: 2.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₄₀F₂N₈O₄.

Desethylene Posaconazole N(triazolonophenyl)-Formyl, CAS: 357189-96-9, stock: 5.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₄₀F₂N₈O₅.

Desethylene Posaconazole N,N’-Diformyl, CAS: 357189-95-8, stock: 3.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₀F₂N₈O₆.

ent-Posaconazole, CAS: /, stock: 9.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₂F₂N₈O₄.

O-Benzyl Posaconazole, CAS: 170985-86-1, stock: 7.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₄₈F₂N₈O₄.

O-Benzyl Posaconazole-d4, CAS: 1246818-95-0, stock: 6.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₄₄D₄F₂N₈O₄.

Posaconazole, CAS: 171228-49-2, stock: 8.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₂F₂N₈O₄.

Posaconazole Imidazolidine Impurity, CAS: 1388148-29-5, stock: 9.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₄₀F₂N₈O₄.

Posaconazole Mono N-Oxide (Regioisomers Mixtures), CAS: 1902954-03-3, 1902954-05-5, stock: 10g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₂F₂N₈O₅.

Posaconazole N-β-D-Glucuronide (>80%), CAS: /, stock: 8.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₃H₅₀F₂N₈O₁₀.

Posaconazole Succinyl Ester, CAS: 1488301-79-6, stock: 8.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₄₆F₂N₈O₇.

Posaconazole-d4, CAS: 1133712-26-1, stock: 6.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₃₈D₄F₂N₈O₄.

[4-[4-(4-Hydroxyphenyl)-1-piperazinyl]phenyl]carbamic Acid Phenyl Ester, CAS: 184177-81-9, stock: 5.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₃N₃O₃.

2-Hydroxymethylpyrrole, CAS: 27472-36-2, stock: 8.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₇NO.

3-Hydroxymethylpyrrole, CAS: 71803-59-3, stock: 1.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₇NO.

Porphobilinogen, CAS: 487-90-1, stock: 6.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₂O₄.

Porphobilinogen-13C3, CAS: 1246820-69-8, stock: 2.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇¹³C₃H₁₄N₂O₄.

(R)-Pomalidomide, CAS: 202271-90-7, stock: 8.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₁N₃O₄.

(S)-Pomalidomide, CAS: 202271-89-4, stock: 1.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₁N₃O₄.

N-(2-Aminoethyl) Pomalidomide BP-1-108 Amide, CAS: /, stock: 7.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₇H₅₂N₆O₉S.

N-(3-Aminoethyl) Pomalidomide SF-1-088 Amide, CAS: /, stock: 9.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₉H₅₄N₆O₁₁S.

N-(3-Aminopropanoyl) Pomalidomide BP-1-108 Amide, CAS: /, stock: 2.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₈H₅₂N₆O₁₀S.

N-(3-Aminopropanoyl) Pomalidomide Hydrochloride, CAS: /, stock: 9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆N₄O₅•HCl.

N-(3-Aminopropanoyl) Pomalidomide SF-1-088 Amide, CAS: /, stock: 6.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₀H₅₄N₆O₁₂S.

N-(3-Aminopropyl) Pomalidomide BP-1-108 Amide, CAS: /, stock: 3.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₈H₅₄N₆O₉S.

N-(3-Aminopropyl) Pomalidomide SF-1-088 Amide, CAS: /, stock: 2.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₀H₅₆N₆O₁₁S.

N-(3-Aminopropyl) Pomalidomide Trifluoroacetic Acid Salt, CAS: 2093388-21-5, stock: 8.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈N₄O₄ • x(C ₂HF₃O₂).

N-(6-Aminohexanoyl) Pomalidomide SF-1-088 Amide, CAS: /, stock: 3.5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₃H₆₀N₆O₁₂S.

N-[2-Aminoethyl] Pomalidomide Trifluoroacetic Acid Salt, CAS: 1957235-67-4, stock: 1.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆N₄O₄  • x(C ₂HF₃O₂).

N-[2-[[2-(2,6-Dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]ethyl]-carbamic Acid 1,1-Dimethylethyl Ester, CAS: 1957235-57-2, stock: 2.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄N₄O₆.

3-Heptyl-2,4-dimethyl-thiazolium Iodide, CAS: 31349-62-9, stock: 3.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂INS.

Platonin Diiodide, CAS: 3571-88-8, stock: 7.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₆₁I₂N₃S₃.

Polyquaternium 10, CAS: 81859-24-7, stock: 1.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  (C₁₆H₄₂Cl₂N₂O₇)ₓ . (C₁₂H₂₁O₁₁)z.

Polyquaternium 6, CAS: 26062-79-3, stock: 8.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  (C₈H₁₆ClN)ₓ.

Dicresulene Hydrate, CAS: /, stock: 7.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆O₈S₂ • x(H ₂O).

1,11-Bis(4-((1,4,8,11-tetraazacyclotetradecan-1-yl)methyl)benzyl)-1,4,8,11-tetraazacyclotetradecane, CAS: 771464-86-9, stock: 6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₈₄N₁₂.

1,4,8,11-tetraazacyclotetradecane Hexa(Trifluoroacetic Acid Salt), CAS: 406939-92-2, stock: 3.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₁F₉N₄O₃.

1,8-Bis(4-((1,4,8,11-tetraazacyclotetradecan-1-yl)methyl)benzyl)-1,4,8,11-tetraazacyclotetradecane, CAS: 414858-02-9, stock: 4.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₈₄N₁₂.

N-(4-Hydroxymethylbenzyl) Cyclam, CAS: 176252-20-3, stock: 4.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₂N₄O.

Plerixafor, CAS: 110078-46-1, stock: 1.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₅₄N₈.

Plerixafor Hexa(Trifluoroacetic Acid Salt), CAS: 406939-93-3, stock: 5.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₄₈F₁₈N₈O₆.

Plerixafor Hydrochloride (1:8), CAS: 155148-31-5, stock: 2.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₆₂Cl₈N₈.

Plerixafor N-1-(4-Methylbenzyl)-1,4,8,11-tetraazacyclotetradecane Hydrochloride, CAS: /, stock: 1.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₈₄N₁₂•HCl.

Plerixafor-d4, CAS: 1246819-87-3, stock: 2.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₅₀D₄N₈.

Plerixafor-d4 Hexa(Trifluoroacetic Acid Salt), CAS: /, stock: 7.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₄₄D₄F₁₈N₈O₆.

2-(3-Aminophenyl)-N,N-dipropylacetamide, CAS: 122520-07-4, stock: 1.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₂N₂O.

4-Deoxypodophyllotoxin, CAS: 19186-35-7, stock: 1.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₂O₇.

4’-Demethyldesoxypodophyllotoxin, CAS: 3590-93-0, stock: 2.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₀O₇.

4’-Demethylepipodophyllotoxin, CAS: 6559-91-7, stock: 9.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₀O₈.

4’-Demethylpicropodophyllin, CAS: 112066-16-7, stock: 8.2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₀O₈.

4’-Demethylpodophyllotoxin, CAS: 40505-27-9, stock: 3.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₀O₈.

Epipodophyllotoxin, CAS: 09/07/4375, stock: 5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₂O₈.

Podophyllotoxin, CAS: 518-28-5, stock: 7.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₂O₈.

Podophyllotoxin 4-O-Glucoside, CAS: 16481-54-2, stock: 3.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₂O₁₃.

Podophyllotoxin-d3, CAS: /, stock: 4.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₉D₃O₈.

Teniposide, CAS: 29767-20-2, stock: 5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₂O₁₃S.

Teniposide-d3, CAS: /, stock: 4.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₂₉D₃O₁₃S.

3,5-Dimethyl-4-[3-(3-methyl-5-isoxazolyl)propoxy]-benzonitrile, CAS: 130226-18-5, stock: 5.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈N₂O₂.

3,5-Dimethyl-4-[3-(3-methyl-5-isoxazolyl)propoxy]-benzonitrile-d8, CAS: /, stock: 8.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₀D₈N₂O₂.

Pleconaril, CAS: 153168-05-9, stock: 1.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈F₃N₃O₃.

Pleconaril-d8 (Major), CAS: 1346602-36-5, stock: 6.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₀D₈F₃N₃O₃.

2,2,4-Trimethyl-1,3-pentanediol Diisobutyrate, CAS: 6846-50-0, stock: 1.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₃₀O₄.

2,2,4-Trimethyl-1,3-pentanediol Diisobutyrate-d7, CAS: /, stock: 6.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆D₁₄O₄.

Plastic Additive 21, CAS: 112-84-5, stock: 8.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₄₃NO.

3,4-Pyridinedicarboxylic Anhydride, CAS: 08/08/4664, stock: 9.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₃NO₃.

6-Desaminoethylamino-6-fluoro Pixantrone, CAS: /, stock: 7.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂FN₃O₂.

9-Desaminoethyl Pixantrone, CAS: /, stock: 9.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄N₄O₂.

9-Desaminoethylamino-9-fluoro Pixantrone, CAS: /, stock: 3.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂FN₃O₂.

Pixantrone Mono Maleinamide Mixture, CAS: /, stock: 5.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₄₂N₁₀O₁₀.

(2-Cyclopropyl-4-phenylquinolin-3-yl)methanol, CAS: /, stock: 2.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₇NO.

(3R,5S,6E)-7-(2-Cyclopropyl-4-phenyl-3-quinolinyl)-3,5-dihydroxy-6-heptenoic Acid Sodium Salt, CAS: /, stock: 1.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₄NNaO₄.

(3R,5S,6E)-7-(2-Cyclopropyl-4-phenyl-3-quinolinyl)-3,5-dihydroxy-6-heptenoic Acid tert-Butyl Ester, CAS: /, stock: 3.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₃NO₄.

(5S,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-5-hydroxy-3-oxo-6-heptenoic Acid Sodium Salt, CAS: /, stock: 9.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₁FNNaO₄.

(E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-5-hydroxy-3-oxo-6-heptenoic Acid Ethyl Ester, CAS: 148901-69-3, stock: 4.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₆FNO₄.

2-((4R,6S)-6-((E)-2-(2-Cyclopropyl-4-phenylquinolin-3-yl)vinyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetic Acid tert-Butyl Ester, CAS: /, stock: 7.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₇NO₄.

2-Cyclopropyl-4-(4-fluorophenyl)-3-quinoline-d5 3-Aldehyde, CAS: 1346597-84-9, stock: 2.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₉D₅FNO.

2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinemethanol, CAS: 121660-11-5, stock: 6.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₆FNO.

2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinemethanol-d5, CAS: 1346600-49-4, stock: 7.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₁D₅FNO.

2-Cyclopropyl-4-phenyl-3-quinolinecarboxylic Acid Methyl Ester, CAS: 868536-53-2, stock: 5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₇NO₂.

2-Cyclopropyl-4-phenylquinoline-3-carbaldehyde, CAS: /, stock: 7.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₅NO.

3-Cyclopropyl-3-oxopropanoic Acid Methyl Ester, CAS: 32249-35-7, stock: 9.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₀O₃.

3-Cyclopropyl-3-oxopropanoic-d5 Acid Methyl Ester, CAS: 1346600-53-0, stock: 3.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅D₅O₃.

3-[(tert-Butyldimethylsilyl)oxy]glutaric Anhydride, CAS: 91424-40-7, stock: 4.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₀O₄Si.

4-(4-Fluorophenyl)-2-cyclopropylquinoline-3-carboxylic Acid Methyl Ester, CAS: 121659-86-7, stock: 3.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₆FNO₂.

4-(4-Fluorophenyl)-2-cyclopropylquinoline-3-carboxylic-d5 Acid Methyl Ester, CAS: 1346598-23-9, stock: 4.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₁D₅FNO₂.

4-Dehydroxy-3-dehydro-pitavastatin-d5 Lactone, CAS: /, stock: 3.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₁₅D₅FNO₂.

5-Oxo Pitavastatin, CAS: 222306-15-2, stock: 4.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₂FNO₄.

6-Cyclopropyl-10-fluoro-7,8-dihydrobenzo[k]phenanthridine, CAS: 1187966-94-4, stock: 3.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₆FN.

6-Cyclopropyl-10-fluorobenzo[k]phenanthridine, CAS: 1187966-95-5, stock: 3.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₄FN.

8-Hydroxy Pitavastatin, CAS: 224320-09-6, stock: 5.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₄FNO₅.

Pitavastatin 1-Phenylethylamide, CAS: /, stock: 7.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₃FN₂O₃.

Pitavastatin 1-Phenylethylamide-d5, CAS: /, stock: 6.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₂₈D₅FN₂O₃.

Pitavastatin Acyl Glucuronide, CAS: 574752-66-2, stock: 4.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₂FNO₁₀.

Pitavastatin Lactone Pitavastatin, CAS: /, stock: 6.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₀H₄₄F₂N₂O₆.

Pitavastatin Methyl Ester, CAS: 849811-78-5, stock: 3.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₆FNO₄.

Pitavastatin-d5 Lactone, CAS: /, stock: 7.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₁₇D₅FNO₃.

Pitavastatin-d5 Sodium Salt, CAS: /, stock: 2.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₁₈D₅FNNaO₄.

(2R-cis)-Methyl 7-Chloro-6,7,8-trideoxy-6-[[(4-ethyl-2-piperidinyl)carbonyl]amino]-1-thio-L-threo-α-D-galacto-octopyranoside, CAS: 78822-41-0, stock: 8.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₃₁ClN₂O₅S.

2-Amino-4-ethylpyridine, CAS: 33252-32-3, stock: 5.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₀N₂.

4-Ethyl-pyridine-2-carboxylic Acid-d5 Hydrochloride, CAS: 1329836-38-5, stock: 9.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅D₅ClNO₂.

4-Ethylpyridine-2-carboxylic Acid Hydrochloride, CAS: 79415-18-2, stock: 8.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀ClNO₂.

Pirlimycin Hydrochloride, CAS: 78822-40-9, stock: 4.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₃₁ClN₂O₅S•xHCl.

Pirlimycin Hydrochloride (Mixture of Diastereomers), CAS: /, stock: 5.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₃₁ClN₂O₅S•HCl.

Pirlimycin-d10 (Major) Hydrochloride (Mixture of Diastereomers), CAS: /, stock: 2.6g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₂D₁₀Cl₂N₂O₅S.

Pirlimycin-d12 (Major) Hydrochloride (Mixture of Diastereomers), CAS: /, stock: 2.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀D₁₂Cl₂N₂O₅S.

Tridehydro Pirlimycin, CAS: 78788-60-0, stock: 1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₅ClN₂O₅S.

Tridehydro Pirlimycin-d5, CAS: /, stock: 5.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀D₅ClN₂O₅S.

Piribedil, CAS: 04/01/3605, stock: 3.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈N₄O₂.

Piribedil Dihydrochloride, CAS: 78213-63-5, stock: 2.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈N₄O₂ •  HCl.

Piribedil Dihydrochloride, CAS: 1451048-94-4, stock: 7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈N₄O₂ • 2(HCl).

Piribedil N-Oxide, CAS: 53954-71-5, stock: 2.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈N₄O₃.

1-(4-Hydroxyphenyl)pyridin-2(1H)-one, CAS: 859538-51-5, stock: 4.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉NO₂.

1-O-(5-Carboxy-N-phenyl-2-1H-pyridone)-D-glucuronic Acid (1:3 α:β mixture), CAS: /, stock: 3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇NO₉.

3-Hydroxy-1-(4-hydroxyphenyl)-5-methylpyridin-2-(1H)-one, CAS: /, stock: 5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃NO₃.

3-Hydroxy-5-methyl-N-phenyl-2-1H-pyridone, CAS: 887406-53-3, stock: 5.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁NO₂.

3-Hydroxy-5-methyl-N-phenyl-2-1H-pyridone-d5, CAS: 1020719-53-2, stock: 3.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₆D₅NO₂.

5-Carboxy-N-phenyl-2-1H-pyridone, CAS: 77837-08-2, stock: 3.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₉NO₃.

5-Carboxy-N-phenyl-2-1H-pyridone, Sodium Salt, CAS: 1189982-99-7, stock: 3.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₈NNaO₃.

5-Carboxy-N-phenyl-2-1H-pyridone-d5, CAS: 1020719-24-7, stock: 9.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₄D₅NO₃.

5-Hydroxymethyl-N-phenyl-2-1H-pyridone, CAS: 887406-49-7, stock: 3.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁NO₂.

5-Hydroxymethyl-N-phenyl-2-1H-pyridone-d5, CAS: 1020719-52-1, stock: 8.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₆D₅NO₂.

5-Methyl-N-phenyl-2-1H-pyridone [Pirfenidone], CAS: 53179-13-8, stock: 4.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁NO.

5-Methyl-N-phenyl-2-1H-pyridone-d5 ( Pirfenidone-d5 ), CAS: 1020719-62-3, stock: 2.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₆D₅NO.

N-(4-Fluorophenyl)pyridin-2(1H)-one, CAS: 60532-42-5, stock: 3.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₈FNO.

N-(4-Hydroxyphenyl)-5-methyl-2-1H-pyridone, CAS: 851518-71-3, stock: 3.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁NO₂.

N-(4-Hydroxyphenyl)-5-methyl-2-1H-pyridone-d4, CAS: 1188263-50-4, stock: 2.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₇D₄NO₂.

N-Phenylpyridin-2(1H)-one, CAS: 13131-02-7, stock: 4.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉NO.

2-[1-(4-Piperonyl)piperazinyl]benzothiazole, CAS: 155106-73-3, stock: 1.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₉N₃O₂S.

2-[2-(2-Butoxyethoxy)ethoxy]tetrahydropyran-d9, CAS: 1346598-46-6, stock: 9.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇D₉O₄.

6-Chloropiperonyl alcohol, CAS: 2591-25-5, stock: 4.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇O₃Cl.

6-Nitropiperonyl Alcohol, CAS: 15341-08-9, stock: 9.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇NO₅.

Methyl Piperonylate, CAS: 326-56-7, stock: 7.6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈O₄.

N-​Methoxy-​N-​methyl-1,​3-​benzodioxole-​5-​acetamide, CAS: 153277-41-9, stock: 5.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃NO₄.

Piperonyl Acetone, CAS: 55418-52-5, stock: 3.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂O₃.

Piperonyl Alcohol, CAS: 495-76-1, stock: 7.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈O₃.

Piperonyl Butoxide, CAS: 51-03-6, stock: 3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₀O₅.

Piperonyl Butoxide-d9, CAS: 1329834-53-8, stock: 6.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁D₉O₅.

Piperonyl Chloride (~75% by weight in CH2Cl2), CAS: 20850-43-5, stock: 4.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇ClO₂.

Piperonyl Isobutyrate, CAS: 05/08/5461, stock: 9.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄O₄.

Piperonylidenemalononitrile, CAS: 2972-82-9, stock: 7.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₆N₂O₂.

Podorhizol β-D-Glucopyranoside, CAS: 17187-73-4, stock: 7.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₄O₁₃.

(+)-cis-10-Methoxyvincamine, CAS: 57430-34-9, stock: 4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₈N₂O₄.

16,17-Dihydroapovincamine, CAS: 57130-30-0, stock: 2.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₆N₂O₂.

16,17-Dihydroapovincamine-d3, CAS: /, stock: 3.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃D₃N₂O₂.

17,18-Dehydroapovincamine, CAS: 50298-88-9, stock: 1.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₂N₂O₂.

17,18-Dehydrovincamine, CAS: 32790-09-3, stock: 6.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₄N₂O₃.

17,18-Dehydrovincamine-d3, CAS: /, stock: 9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁D₃N₂O₃.

2-Pyridinol, CAS: 72762-00-6, stock: 3.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅NO.

Carphedone, CAS: 77472-70-9, stock: 1.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄N₂O₂.

Dehydro Levetiracetam, CAS: 358629-47-7, stock: 8.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂N₂O₂.

Epivincamine, CAS: 6835-99-0, stock: 4.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₆N₂O₃.

Epivincamine-d3, CAS: /, stock: 1.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃D₃N₂O₃.

Ethyl 17,18-Didehydro Apovincaminate, CAS: 742670-81-1, stock: 3.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₄N₂O₂.

Levetiracetam, CAS: 102767-28-2, stock: 9.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₄N₂O₂.

Levetiracetam-d3, CAS: 1217851-16-5, stock: 4.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁D₃N₂O₂.

Levetiracetam-d3 (contains d0), CAS: 1217851-16-5, stock: 9.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁D₃N₂O₂.

Levetiracetam-d6, CAS: 1133229-29-4, stock: 7.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈D₆N₂O₂.

Levetiracetam-d6, CAS: 1133229-30-7, stock: 1.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈D₆N₂O₂.

Piracetam, CAS: 7491-74-9, stock: 3.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀N₂O₂.

Piracetam-d8, CAS: 1329799-64-5, stock: 9.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₂D₈N₂O₂.

Vincamine, CAS: 1617-90-9, stock: 8.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₆N₂O₃.

Vincaminic Acid, CAS: 28152-73-0, stock: 7.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄N₂O₃.

(-)-(2R,5S)-1-Allyl-2,5-dimethylpiperazine, CAS: 155836-78-5, stock: 3.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₈N₂.

(2R)-1,4-DiBoc-piperazine-2-carboxylic Acid, CAS: 173774-48-6, stock: 3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₆N₂O₆.

(2R,3R)-2,3-Dimethyl-1-piperazinecarboxylic Acid 1,1-Dimethylethyl Ester, CAS: 1240583-15-6, stock: 2.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₂N₂O₂.

(2R,3R)-2,3-Dimethyl-1-piperazinecarboxylic-d4 Acid 1,1-Dimethylethyl Ester, CAS: /, stock: 4.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₈D₄N₂O₂.

(2R,5R)-2,5-Dimethyl-piperazine-1-carboxylic Acid tert-Butyl Ester, CAS: 1240586-48-4, stock: 4.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₂N₂O₂.

(2R,5S)-1,2,5-Trimethylpiperazine Oxalate, CAS: 1046788-78-6, stock: 5.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₆N₂ • C ₂H₂O₄.

(2R,5S)-1-N-Boc-2,5-dimethylpiperazine, CAS: 194032-41-2, stock: 1.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₂N₂O₂.

(2S)-2-Methylpiperazine, CAS: 74879-18-8, stock: 9.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₂N₂.

(2S)-Hexahydro-2-methyl-1H-1,4-diazepine-1-carboxylic Acid 1,1-Dimethylethyl Ester, CAS: 1035226-84-6, stock: 9.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₂N₂O₂.

(2S,5S)-1-Boc-2,5-dimethylpiperazine, CAS: 1238951-37-5, stock: 9.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₂N₂O₂.

(2S,5S)-3,6-Dioxo-5-(phenylmethyl)-2-piperazinepropanenitrile, CAS: 120539-80-2, stock: 6.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅N₃O₂.

(2S-cis)-3,6-Dioxo-5-(phenylmethyl)-2-piperazineacetonitrile, CAS: 149796-08-7, stock: 1.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃N₃O₂.

(3-Bromo-4-methylphenyl)acetic Acid, CAS: 1201633-84-2, stock: 4.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉BrO₂.

(3R)-3-(Trifluoromethyl)-1-piperazinecarboxylic acid 1,1-Dimethylethyl Ester, CAS: 1240587-88-5, stock: 8.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₇F₃N₂O₂.

(3R)-3-[[2-(1,3-Benzodioxol-5-ylcarbonyl)-1H-indol-3-yl]methyl]-1-methyl-2,5-piperazinedione, CAS: 1220393-12-3, stock: 7.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₉N₃O₅.

(3R,5R)-3,5-Dimethyl-1-piperazinecarboxylic Acid 1,1-Dimethylethyl Ester, CAS: 438049-91-3, stock: 7.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₂N₂O₂.

(3s)-1,3-Dimethylpiperazine Dihydrochloride, CAS: 1152110-30-9, stock: 2.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₆Cl₂N₂.

(3S)-3-(Trifluoromethyl)-1-piperazinecarboxylic acid 1,1-Dimethylethyl Ester, CAS: 1240587-95-4, stock: 6.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₇F₃N₂O₂.

(3S)-4-Boc-1-carboxymethyl-3-benzyl-piperazin-2-one, CAS: 215121-89-4, stock: 4.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₄N₂O₅.

(3S)-4-Boc-1-carboxymethyl-3-isobutyl-piperazin-2-one, CAS: 959584-21-5, stock: 5.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₆N₂O₅.

(3S)-4-Boc-1-carboxymethyl-3-methyl-piperazin-2-one, CAS: 959571-65-4, stock: 3.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₀N₂O₅.

(3S,4R)-1-Boc-4-(4-chlorophenyl)pyrrolidine-3-carboxylic Acid, CAS: 851484-56-5, stock: 6.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₀ClNO₄.

(3S,6R)-3,6-Bis(hydroxymethyl)piperazine-2,5-dione, CAS: 15996-16-4, stock: 5.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀N₂O₄.

(3S,6S)-3-((1H-indol-3-yl)methyl)-6-(4-hydroxybenzyl)piperazine-2,5-dione, CAS: 20829-53-2, stock: 3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₉N₃O₃.

(3Z,6Z)-3,6-Dibenzylidene-1,4-dimethylpiperazine-2,5-dione, CAS: 94514-45-1, stock: 7.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₈N₂O₂.

(4-Acetyl-piperazin-1-yl)acetic Acid, CAS: 705941-45-3, stock: 7.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₄N₂O₃.

(4-Benzyl-piperazin-1-yl)-acetic Acid, CAS: 119929-87-2, stock: 1.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈N₂O₂.

(4-Benzylpiperazin-1-yl)acetic Acid Ethyl Ester-d8, CAS: 23173-76-4, stock: 5.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄D₈N₂O₂.

(6R)-6-Ethyl-1,4-bis[(1S)-1-(4-methoxyphenyl)ethyl]-2,5-piperazinedione-3,3,6-d3, CAS: 1246496-66-1, stock: 9.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₇D₃N₂O₄.

(6S)-6-Ethyl-1,4-bis[(1S)-1-(4-methoxyphenyl)ethyl]-2,5-piperazinedione-3,3,6-d3, CAS: 1246496-59-2, stock: 9.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₇D₃N₂O₄.

(8aR)-Hexahydro-2-methyl-7-(2-pyridinylmethyl)-imidazo[1,5-a]pyrazin-3(2H)-one, CAS: 1396441-96-5, stock: 3.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈N₄O.

(±)-2-Methyl-d3-piperazine-2,3,3,5,5,6,6-d7, CAS: /, stock: 3.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅D₇N₂.

(Carboxymethyl)-N’-methylpiperazine, CAS: 54699-92-2, stock: 7.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₄N₂O₂.

(α1S,α4S,2S,5S)-2,5-Dimethyl-3,6-dioxo-α1,α4-bis(2-phenylethyl)-1,4-piperazinediacetic Acid 1,4-Diethyl Ester, CAS: 151387-05-2, stock: 2.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₈N₂O₆.

(R) 1-Boc-2-(methylcarbamoyl)piperazine Hydrochloride, CAS: 1217826-94-2, stock: 8.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₁N₃O₃ • HCl.

(R)-(+)-Dropropizine, CAS: 99291-24-4, stock: 1.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₀N₂O₂.

(R)-(+)-Dropropizine-d4, CAS: /, stock: 6.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆D₄N₂O₂.

(R)-(-)-2-Methylpiperazine, CAS: 75336-86-6, stock: 2.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₂N₂.

(R)-1,3Dimethylpiperazine Dihydrochloride, CAS: 1152110-26-3, stock: 3.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₄N₂ •  2HCl.

(R)-1,4-(Di-boc)-2-(hydroxymethyl)piperazine, CAS: 1159598-21-6, stock: 6.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₈N₂O₅.

(R)-1-Benzoyl-4-(4-iodophenyl)sulfonyl-3-methylpiperazine, CAS: 948990-71-4, stock: 7.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₉IN₂O₃S.

4’-(7-Dechloroquinolinyl) Piperaquine, CAS: 4039-00-3, stock: 6.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₈ClN₅.

5-Chloro 7-Deschloropiperaquine, CAS: 918879-09-1, stock: 5.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₂Cl₂N₆.

(R)-1-Benzyl 2-methyl piperazine-1,2-dicarboxylate, CAS: 1217598-28-1, stock: 7.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈N₂O₄.

(R)-1-Benzyl 4-tert-Butyl 2-(Aminomethyl)piperazine-1,4-dicarboxylate, CAS: 1212316-00-1, stock: 6.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₇N₃O₄.

5-Chloro 7-Deschloropiperaquine-d6, CAS: /, stock: 2.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₆D₆Cl₂N₆.

(R)-1-Boc-2-Benzylpiperazine, CAS: 947684-78-8, stock: 4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₄N₂O₂.

(R)-1-Boc-2-ethyl-piperazine, CAS: 393781-70-9, stock: 3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₂N₂O₂.

7-Chloro-4-[4-(3-chloropropyl)-1-piperazinyl]-quinoline, CAS: 4038-99-7, stock: 2.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₉Cl₂N₃.

N-4-(7-Chloroquinolinyl)-N’-3-[4-(7-Chloroquinolinyl)]-1-piperazinyl]-1-propylethylenediamine, CAS: /, stock: 3.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₀Cl₂N₆.

(R)-1-Boc-2-isobutyl-piperazine, CAS: 1217599-13-7, stock: 7.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₆N₂O₂.

(R)-1-Boc-2-methylpiperazine, CAS: 170033-47-3, stock: 4.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₀N₂O₂.

Piperaquine N-Oxide, CAS: 925673-46-7, stock: 3.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₂Cl₂N₆O.

(R)-1-Boc-2-propyl-piperazine, CAS: 1212252-88-4, stock: 5.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₄N₂O₂.

(R)-1-Boc-Piperazine-2-carboxylic Acid, CAS: 278788-60-6, stock: 2.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₈N₂O₄.

Piperaquine-d6 N-Oxide, CAS: /, stock: 8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₆D₆Cl₂N₆O.

(R)-1-Boc-piperazine-3-carboxylic Acid, CAS: 192330-11-3, stock: 5.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₈N₂O₄.

(R)-1-Cyclohexyl-2-methylpiperazine Dihydrochloride, CAS: 1134603-02-3, stock: 6.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₂N₂ • 2HCl.

(R)-1-Cyclohexyl-3-methyl-piperazine Dihydrochloride, CAS: 1187928-07-9, stock: 8.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₂N₂ • 2HCl.

(R)-1-Cyclohexyl-3-methyl-piperazine Oxalate, CAS: 1187930-96-6, stock: 9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₂N₂ • C ₂H₂O₄.

(R)-1-Ethyl-2-methyl-piperazine, CAS: 1187931-30-1, stock: 1.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₆N₂.

(R)-1-Fmoc-2-methyl-piperazine, CAS: 1187930-73-9, stock: 7.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂N₂O₂.

(R)-1-Isopropyl-2-methyl-piperazine, CAS: 1187929-51-6, stock: 5.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₈N₂.

(R)-1-N-Boc-2-benzylpiperazine Hydrochloride, CAS: 1217466-36-8, stock: 1.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₄N₂O₂ • HCl.

(R)-1-N-Boc-2-methyl Piperazine Hydrochloride, CAS: 1000853-53-1, stock: 1.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₁ClN₂O₂.

(R)-1-N-Cbz-2-methyl-piperazine Hydrochloride, CAS: 1217848-48-0, stock: 3.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈N₂O₂ • (HCl).

(R)-1-N-CBZ-2-Methylpiperazine, CAS: 923565-99-5, stock: 1.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈N₂O₂.HCl.

(R)-1-N-Fmoc-2-methyl-piperazine Hydrochloride, CAS: 1187930-83-1, stock: 1.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂N₂O₂ •  HCl.

(R)-2-Ethylpiperazine Dihydrochloride, CAS: 438050-07-8, stock: 7.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₆Cl₂N₂.

(R)-2-Isopropylpiperazine Dihydrochloride, CAS: 1217663-39-2, stock: 8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₆N₂ • 2HCl.

(R)-2-Methylpiperazine Dihydrochloride, CAS: 75336-89-9, stock: 4.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₂N₂ • 2(HCl).

(R)-2-Phenethyl-piperazine Dihydrochloride, CAS: 1217452-20-4, stock: 8.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈N₂ • 2HCl.

(R)-3-(Benzyloxy)-2-hydroxypropanoic Acid, CAS: 130111-08-9, stock: 4.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅₀H₁₂O₄.

(R)-3-Isopropyl-2,5-piperazinedione, CAS: 143673-66-9, stock: 2.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₂N₂O₂.

(R)-3-Methyl-1-(tetrahydro-pyran-4-yl)-piperazine, CAS: 1187931-25-4, stock: 2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₀N₂O.

(R)-4-Benzyl-1-(tert-butoxycarbonyl)piperazine-2-carboxylic Acid, CAS: 1245643-13-3, stock: 3.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₄N₂O₄.

(R)-4-Boc-1-cbz-2-methyl-piperazine, CAS: 1163793-25-6, stock: 2.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₆N₂O₄.

(R)-4-Boc-2-methylpiperazine, CAS: 163765-44-4, stock: 1.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₀N₂O₂.

(R)-4-N-Boc-2-ethylpiperazine Hydrochloride, CAS: 1217462-84-4, stock: 3.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₂N₂O₂ • HCl.

(R)-4-N-Trityl-2-methyl Piperazine, CAS: 313657-75-9, stock: 2.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₆N₂.

(R)-Benzyl 3-(hydroxymethyl)piperazine-1-carboxylate, CAS: 930837-03-9, stock: 5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈N₂O₃.

(R)-Benzyl 3-Methylpiperazine-1-carboxylate, CAS: 623586-00-5, stock: 2.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈N₂O₂.

(R)-CPP, CAS: 126453-07-4, stock: 4.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₇N₂O₅P.

(R)-Doxazosin, CAS: 70918-17-1, stock: 6.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₅N₅O₅.

(R)-Doxazosin-d8, CAS: /, stock: 8.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₇D₈N₅O₅.

(R)-Methyl Piperazine-2-carboxylate Dihydrochloride, CAS: 637027-25-9, stock: 7.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂N₂O₂ • 2(HCl).

(R)-N-1-Boc-n-4-cbz-2-piperazine carboxylic acid, CAS: 138775-02-7, stock: 8.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₄N₂O₆.

(R)-Piperazine-2-carboxylic Acid Dihydrochloride, CAS: 126330-90-3, stock: 5.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀N₂O₂ • 2(HCl).

(R)-Ranolazine, CAS: 114246-80-9, stock: 7.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₃N₃O₄.

(R)-tert-Butyl (1-((4-Methylquinazolin-2-yl)methyl)piperidin-3-yl)carbamate, CAS: /, stock: 1.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₆N₄O₂.

(R)-tert-Butyl 2-isopropylpiperazine-1-carboxylate, CAS: 674792-04-2, stock: 9.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₄N₂O₂.

(R)-tert-Butyl 3-Ethylpiperazine-1-carboxylate, CAS: 438050-08-9, stock: 8.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₂N₂O₂.

(R)-tert-Butyl 3-Isopropylpiperazine-1-carboxylate Hydrochloride, CAS: 1217444-26-2, stock: 3.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₄N₂O₂ • HCl.

(R)-Zopiclone, CAS: 138680-08-7, stock: 5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇ClN₆O₃.

(R)-Zopiclone-d8, CAS: /, stock: 8.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₉D₈ClN₆O₃.

(R,S)-4-Fmoc-3-carboxymethyl-piperazin-2-one, CAS: 1029630-75-8, stock: 8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₀N₂O₅.

(S)-(+)-Doxazosin, CAS: 104874-86-4, stock: 6.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₅N₅O₅.

(S)-(+)-Doxazosin-d8, CAS: /, stock: 8.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₇D₈N₅O₅.

(S)-(-)-Dropropizine, CAS: 99291-25-5, stock: 1.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₀N₂O₂.

(S)-(-)-Dropropizine-d4, CAS: /, stock: 7.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆D₄N₂O₂.

(S)-1,3-Dimethylpiperazine, CAS: 1152367-80-0, stock: 3.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₄N₂.

(S)-1,4-Benzodioxan-2-carboxypiperazine, CAS: 401941-54-6, stock: 2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆N₂O₃.

(S)-1-(tert-Butoxycarbonyl)-5-oxopiperazine-2-carboxylic Acid, CAS: 1033713-11-9, stock: 6.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆N₂O₅.

(S)-1-Benzyl 3-Methyl Piperazine-1,3-dicarboxylate Hydrochloride, CAS: 1217471-97-0, stock: 2.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈N₂O₄ • HCl.

(S)-1-Benzyl-3-ethylpiperazine-2,5-dione, CAS: 325145-36-6, stock: 6.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆N₂O₂.

(S)-1-Boc-2-benzylpiperazine, CAS: 169447-86-3, stock: 5.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₄N₂O₂.

(S)-1-BOC-2-Ethylpiperazine, CAS: 325145-35-5, stock: 3.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₂N₂O₂.

(S)-1-Boc-2-hydroxymethyl-piperazine, CAS: 1030377-21-9, stock: 6.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₀N₂O₃.

(S)-1-Boc-2-methylpiperazine, CAS: 169447-70-5, stock: 2.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₀N₂O₂.

(S)-1-Boc-3-hydroxymethyl-piperazine, CAS: 314741-40-7, stock: 5.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₀N₂O₃.

(S)-1-Boc-3-Isopropylpiperazine, CAS: 475272-54-9, stock: 3.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₄N₂O₂.

(S)-1-BOC-4-[2-(Cbz-Amino)isopentanoyl]piperazine, CAS: 1420804-55-2, stock: 6.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₃N₃O₅.

(S)-1-Cyclohexyl-2-methyl-piperazine Dihydrochloride, CAS: 1134681-40-5, stock: 4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₂N₂ • 2HCl.

(S)-1-Cyclohexyl-3-methyl-piperazine Oxalate, CAS: 1187931-05-0, stock: 7.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₂N₂ • C ₂H₂O₄.

(S)-1-Ethyl-2-methyl-piperazine, CAS: 1033717-23-5, stock: 8.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₆N₂.

(S)-1-N-Boc-2-methyl Piperazine Hydrochloride, CAS: 960283-58-3, stock: 1.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₀N₂O₂ • HCl.

(S)-1-N-Boc-3-cyanopiperazine, CAS: 1217650-60-6, stock: 5.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₇N₃O₂.

(S)-1-N-Boc-4-N-fmoc-piperazine-2-carboxylic Acid, CAS: 1034574-30-5, stock: 4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₈N₂O₆.

(S)-1-N-Boc-Piperazine-2-carboxylic Acid Methyl Ester, CAS: 796096-64-5, stock: 1.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₀N₂O₄.

(S)-1-N-Cbz-2-methyl-piperazine, CAS: 923565-98-4, stock: 2.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈N₂O₂.

(S)-1-N-Cbz-2-methyl-piperazine Hydrochloride, CAS: 1217720-49-4, stock: 4.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈N₂O₂ • (HCl).

(S)-1-N-Cbz-piperazine-2-carboxylic Acid Methyl Ester Hydrochloride, CAS: 1217444-22-8, stock: 9.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈N₂O₄ • HCl.

(S)-1N-Boc-2-(S-1-methylpropyl)piperazine Hydrochloride, CAS: 1217442-47-1, stock: 4.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₆N₂O₂ • HCl.

(S)-2-(4-Ethyl-2,3-dioxopiperazine-1-carboxamido)-2-phenylacetic (Methyl Carbonic) Anhydride, CAS: /, stock: 1.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉N₃O₇.

(S)-2-Trifluoromethyl-piperazine, CAS: 1187931-35-6, stock: 4.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉N₂F₃.

(S)-3-Methyl-1-(tetrahydro-pyran-4-yl)-piperazine, CAS: 1187931-31-2, stock: 4.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₀N₂O.

(S)-4-N-Boc-piperazine-2-carboxylic Acid Methyl Ester Hydrochloride, CAS: 1217702-80-1, stock: 8.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₀N₂O₄ • HCl.

(S)-4-N-Trityl-2-methyl-Piperazine, CAS: 625843-74-5, stock: 1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₆N₂.

(S)-Benzyl 3-methylpiperazine-1-carboxylate, CAS: 612493-87-5, stock: 3.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈N₂O₂.

(S)-Methyl Piperazine-2-Carboxylate Dihydrochloride, CAS: 1334173-77-1, stock: 9.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂N₂O₂ • 2(HCl).

(S)-Piperazine-2-carbonitrile, CAS: 1212303-37-1, stock: 5.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉N₃.

(S)-Piperazine-2-carboxylic Acid Dihydrochloride, CAS: 158663-69-5, stock: 9.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀N₂O₂ • 2(HCl).

(S)-Ranolazine, CAS: 114246-81-0, stock: 7.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₃N₃O₄.

(S)-WAY 100135 Dihydrochloride, CAS: 149007-54-5, stock: 3.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₃N₃O₂ • 2 HCl.

(S)​-​1-​(4-​Chlorophenyl)​ethanol, CAS: 99528-42-4, stock: 7.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉ClO.

(S,S)-3-Isopropyl-6-methylpiperazine-2,5-dione, CAS: 15136-26-2, stock: 6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₄N₂O₂.

(Z)-Cinnarizine, CAS: 750512-44-8, stock: 7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₈N₂.

(Z)-Cinnarizine-d8, CAS: 1185242-27-6, stock: 1.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₀D₈N₂.

1,1-Difluorocyclopropane-1-dibenzosuberyl Piperazine Trifluoroacetic Acid Salt, CAS: /, stock: 2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₁F₅N₂O₂.

1,1’-(Piperazine-1,4-diyl)diethanone, CAS: 18940-57-3, stock: 5.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₄N₂O₂.

1,1’-Ethylenedipiperazine Hydrochloride Salt, CAS: /, stock: 3.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₂N₄ • x(HC l).

1,2,3-Benzotriazin-4(3H)-one, CAS: 90-16-4, stock: 3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅N₃O.

1,2-Dimethylpiperazine, CAS: 25057-77-6, stock: 7.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₄N₂.

1,3-Bis((4-((4-chlorophenyl)(phenyl)methyl)piperazin-1-yl)methyl)benzene, CAS: 1207847-84-4, stock: 8.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₄₄Cl₂N₄.

1,3-Bis-[4-(3-chlorophenyl)piperazin-1-yl]propane, CAS: 07/09/6323, stock: 8.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₀Cl₂N₄.

1,4-Bis(2,4,5-trimethoxybenzyl)piperazine, CAS: 510718-17-9, stock: 1.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₄N₂O₆.

1,4-Bis(2-Aminophenyl)piperazine, CAS: 29549-88-0, stock: 2.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₀N₄.

1,4-Bis(3,4,5-trimethoxybenzyl)piperazine Dihydrochloride, CAS: 1257-12-1, stock: 9.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₆Cl₂N₂O₆.

1,4-Bis(3-(2-(trifluoromethyl)-10H-phenothiazin-10-yl)propyl)piperazine, CAS: /, stock: 2.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₃₄F₆N₄S₂.

1,4-Bis(3-(2-(trifluoromethyl)-10H-phenothiazin-10-yl)propyl)piperazine-d8, CAS: /, stock: 3.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₂₆D₈F₆N₄S₂.

1,4-Bis(3-(4-(7-chloroquinolin-4-yl)piperazin-1-yl)propyl)piperazine, CAS: 86486-21-7, stock: 5.5g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₄₆Cl₂N₈.

1,4-Bis(3-aminopropyl)piperazine, CAS: 7209-38-3, stock: 2.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₄N₄.

1,4-Bis(3-chlorophenyl)-piperazine, CAS: 79975-63-6, stock: 9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆Cl₂N₂.

1,4-Bis(3-nitropyridin-2-yl)piperazine, CAS: 5086-48-6, stock: 6.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₄N₆O₄.

1,4-bis(4-Chlorobenzoyl)piperazine, CAS: 107785-63-7, stock: 6.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₆N₂O₂Cl₂.

1,4-bis(7-Chloroquinolin-4-yl)piperazine, CAS: 31502-87-1, stock: 8.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₈Cl₂N₄.

1,4-Bis(benzhydryl)piperazine-d8 Dihydrochloride, CAS: 1329634-36-7, stock: 8.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₄D₈Cl₂N₂.

1,4-Bis(tert-boc)piperazine-d8, CAS: 1246816-49-8, stock: 5.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈D₈N₂O₄.

1,4-Bis-(2-hydroxy-1-phenylethyl)piperazine-2,5-dione, CAS: 7592-99-6, stock: 3.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂N₂O₄.

1,4-Bis[(1S)-1-(4-methoxyphenyl)ethyl]-2,5-piperazinedione, CAS: 1141931-86-3, stock: 4.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₆N₂O₄.

1,4-Bis[(1S)-1-(4-methoxyphenyl)ethyl]-2,5-piperazinedione-d4, CAS: 1246496-54-7, stock: 6.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₂D₄N₂O₄.

1,4-Bis[(3-Iodophenyl)carbonyl]piperazine, CAS: 324776-77-4, stock: 4.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₆I₂N₂O₂.

1,4-Di-Boc-piperazine-2-carboxylic Acid, CAS: 181955-79-3, stock: 4.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₆N₂O₆.

1,4-Di-tert-butyl 2-Methyl Piperazine-1,2,4-tricarboxylate, CAS: 171504-98-6, stock: 8.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₈N₂O₆.

1,4-Di-tert-butyl piperazine-1,4-dicarboxylate, CAS: 76535-75-6, stock: 1.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₆N₂O₄.

1,4-Diazabicyclo[2.2.2]octane, CAS: 280-57-9, stock: 9.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂N₂.

1,4-Dibenzyl-piperazine-2,5-dione, CAS: 42492-87-5, stock: 6.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈N₂O₂.

1,4-Dibenzylpiperazine, CAS: 1034-11-3, stock: 4.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₂N₂.

1,4-Dibenzylpiperazine Dihydrochloride, CAS: 2298-55-7, stock: 5.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₄Cl₂N₂.

1,4-Dibenzylpiperazine-d4 Dihydrochloride, CAS: 118221-01-5, stock: 5.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₀D₄Cl₂N₂.

1,4-Diformylpiperazine, CAS: 4164-39-0, stock: 9.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀N₂O₂.

1,4-Diisobutyryl-piperazine, CAS: 18940-58-4, stock: 9.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂N₂O₂.

1,4-Dimethyl-2,6-piperazinediacetic Acid Dimethyl Ester, CAS: /, stock: 1.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂N₂O₄.

1,4-Dimethylpiperazine-2-carboxylic Acid Dihydrochloride, CAS: 1174064-55-1, stock: 6.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₄N₂O₂ • 2HCl.

1,4-Dinitrosopiperazine, CAS: 140-79-4, stock: 5.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₈N₄O₂.

1,4-Dinitrosopiperazine-d8, CAS: 69340-07-4, stock: 7.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄D₈N₄O₂.

1,4-Piperazinediethylamine, CAS: 6531-38-0, stock: 8.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₂₀N₄.

1,4-Piperazinediethylamine-d8, CAS: /, stock: 9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂D₈N₄.

1,8-Dioxo-1H,2H,3H,4H,8H-pyrido[1,2-a]piperazine-6-carboxylic Acid, CAS: 5368-42-3, stock: 1.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈N₂O₄.

1-((4-Chlorophenyl)sulfonyl)-4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)piperazine, CAS: 1073354-20-7, stock: 2.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₇BN₃O₄SCl.

1-((4-Chlorophenyl)[2-(trifluoromethyl)phenyl]methyl)piperazine, CAS: 512775-99-4, stock: 1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈ClF₃N₂.

1-((4-Fluorophenyl)[4-(trifluoromethyl)phenyl]methyl)piperazine Oxalate, CAS: 1177325-77-7, stock: 3.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈F₄N₂ •C₂H₂O₄.

1-((6-Bromopyridin-3-yl)methyl)-4-ethylpiperazine, CAS: 1231930-25-8, stock: 9.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈BrN₃.

1-(1,3,5-Trimethyl-1H-pyrazol-4-ylmethyl)-piperazine Dihydrochloride, CAS: 1185304-15-7, stock: 5.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₀N₄ •  2HCl.

1-(1,3-Dimethylbutyl)piperazine, CAS: 1171587-00-0, stock: 7.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₂N₂.

1-(1,4-Benzodioxan-2-ylcarbonyl)piperazine-d8, CAS: 1006717-20-9, stock: 5.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₈D₈N₂O₃.

1-(1-Adamantyl)piperazine, CAS: 19984-46-4, stock: 4.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₄N₂.

1-(1-Methyl-1H-imidazol-2-yl)piperazine, CAS: 113049-35-7, stock: 6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₄N₄.

1-(1-Methyl-1H-pyrazol-4-yl)piperazine, CAS: 1174207-79-4, stock: 6.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₄N₄.

1-(1-Methylpiperidin-4-yl)piperazine, CAS: 23995-88-2, stock: 9.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₁N₃.

1-(1-Naphthyl)piperazinemiddotHCl, CAS: 104113-71-5, stock: 9.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆N₂•HCl.

1-(1-Naphthylmethyl)piperazine, CAS: 40675-81-8, stock: 4.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈N₂.

1-(1-Oxidobenzo[d]isothiazol-3-yl)piperazine 1-Oxide Hydrochloride, CAS: /, stock: 5.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄ClN₃O₂S.

1-(1-Phenyl-1H-tetrazol-5-yl)piperazine Hydrochloride, CAS: 1171471-37-6, stock: 5.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄N₆ • HCl.

1-(1-Phenylethyl)piperazine, CAS: 69628-75-7, stock: 9.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈N₂.

1-(1-Propylpiperidin-4-yl)piperazine, CAS: 1082511-85-0, stock: 7.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₅N₃.

1-(1-{3-[3-(Trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl}ethyl)piperazine Dihydrochloride, CAS: 1169989-01-8, stock: 6.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₇N₄OF₃ • 2HCl.

1-(1H-Imidazol-2-ylmethyl)piperazine, CAS: 1179943-93-1, stock: 7.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₄N₄.

1-(1H-Pyrazole-4-carbonyl)-4-(pyridin-2-yl)piperazine, CAS: 1153251-03-6, stock: 3.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅N₅O.

1-(1H-Pyrrol-3-yl)piperazine, CAS: 1368699-70-0, stock: 3.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₃N₃.

1-(2,2,2-Trifluoro-1-phenylethyl)piperazine, CAS: 1076195-24-8, stock: 7.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅N₂F₃.

1-(2,2,2-Trifluoroethyl)piperazine, CAS: 13349-90-1, stock: 2.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁N₂F₃.

1-(2,2-Dimethoxyethyl)piperazine, CAS: 82516-03-8, stock: 6.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₈N₂O₂.

1-(2,3,5,6-Tetramethylbenzenesulfonyl)piperazine Hydrochloride, CAS: 1170478-53-1, stock: 2.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₂N₂O₂S • HCl.

1-(2,3-Dihydro[2,4’-bibenzo[b]thiophen]-4-yl)-piperazine, CAS: 1420987-85-4, stock: 6.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₀N₂S₂.

1-(2,3-Dimethoxybenzoyl)piperazine Hydrochloride, CAS: 1221723-48-3, stock: 3.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈N₂O₃ • HCl.

1-(2,3-Dimethylphenyl)-piperazine, CAS: 1013-22-5, stock: 3.6g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈N₂.

1-(2,3-Dimethylphenyl)-piperazine-D8, CAS: /, stock: 3.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₀D₈N₂.

1-(2,3-Dimethylphenyl)piperazine hydrochloride, CAS: 80836-96-0, stock: 9.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₉ClN₂.

1-(2,4,5-Trimethoxybenzyl)piperazine Dihydrochloride, CAS: /, stock: 1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₄Cl₂N₂O₃.

1-(2,4,6-Trimethoxybenzyl)piperazine Dihydrochloride, CAS: 113698-83-2, stock: 1.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₄Cl₂N₂O₃.

1-(2,4-Dichlorobenzyl)piperazine, CAS: 51619-56-8, stock: 6.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄N₂Cl₂.

1-(2,4-Dichlorobenzyl)piperazine Dihydrochloride, CAS: 07/11/6270, stock: 2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅Cl₃N₂.

1-(2,4-Dichlorophenyl)piperazine Dihydrochloride, CAS: 827614-48-2, stock: 4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₂Cl₂ • 2(HCl).

1-(2,4-Difluorobenzoyl)piperazine Hydrochloride, CAS: 1065586-37-9, stock: 5.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂N₂OF₂ • HCl.

1-(2,4-Difluorophenyl)piperazine, CAS: 115761-79-0, stock: 5.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂F₂N₂.

1-(2,4-Dimethoxybenzoyl)piperazine Hydrochloride, CAS: 1026767-54-3, stock: 1.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈N₂O₃ • HCl.

1-(2,4-Dimethylphenyl)piperazine, CAS: 1013-76-9, stock: 2.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈N₂.

1-(2,4-Dinitrophenyl)-3-methyl-piperazine hydrochloride, CAS: 1890937-94-6, stock: 7.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅ClN₄O₄.

1-(2,4-Dinitrophenyl)-3-methylpiperazine, CAS: 298230-11-2, stock: 4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅ClN₄O₄.

1-(2,4-Dinitrophenyl)-piperazine hydrochloride, CAS: 125422-00-6, stock: 4.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃ClN₄O₄.

1-(2,4-Dinitrophenyl)piperazine Hydrochloride, CAS: 31284-04-5, stock: 1.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₄O₄ • HCl.

1-(2,5-Dichlorophenyl)piperazine, CAS: 1013-27-0, stock: 1.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₂Cl₂.

1-(2,5-Dichlorophenyl)piperazine Hydrochloride, CAS: 119438-13-0, stock: 7.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₂Cl₂ • HCl.

1-(2,5-Difluorobenzoyl)piperazine Hydrochloride, CAS: 1221724-79-3, stock: 3.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂N₂OF₂ • HCl.

1-(2,5-Dimethoxybenzyl)piperazine Hydrochloride, CAS: 374897-99-1, stock: 5.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₀N₂O₂ • HCl.

1-(2,5-Dimethyl-1H-pyrrol-3-yl)piperazine, CAS: 1509180-60-2, stock: 3.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₇N₃.

1-(2,5-Dimethylfuran-3-carbonyl)piperazine Hydrochloride, CAS: 1193387-23-3, stock: 3.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₂O₂ • HCl.

1-(2,5-Dimethylphenyl)piperazine, CAS: 1013-25-8, stock: 9.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈N₂.

1-(2,6-Dichlorobenzyl)piperazine, CAS: 102292-50-2, stock: 2.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄Cl₂N₂.

1-(2,6-Dichlorophenyl)piperazine Hydrochloride, CAS: 1507372-81-7, stock: 6.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃Cl₃N₂.

1-(2,6-Dichlorophenyl)piperazine-d8 Hydrochloride, CAS: /, stock: 7.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₅D₈Cl₃N₂.

1-(2,6-Dimethylphenyl)piperazine, CAS: 1012-91-5, stock: 5.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈N₂.

1-(2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propan-2-yl)piperazine, CAS: /, stock: 3.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₁BN₂O₂.

1-(2-(Benzhydryloxy)ethyl-4-(3-phenylpropyl)piperazine, CAS: 76778-22-8, stock: 3.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₄N₂O.

1-(2-(Decanoyloxy)ethyl)-4-(3-(2-(trifluoromethyl)-10H-phenothiazin-10-yl)propyl)piperazine 1, 4-Dioxide, CAS: 76005-65-7, stock: 7.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₄F₃N₃O₄S.

1-(2-(Trifluoromethyl)phenyl)piperazine, CAS: 63854-31-9, stock: 1.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃N₂F₃.

1-(2-Aminoethyl)-4-benzylpiperazine, CAS: 4553-21-3, stock: 9.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₁N₃.

1-(2-Aminoethyl)-4-methylpiperazine Hydrochloride, CAS: /, stock: 4.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₇N₃ • x(HCl).

1-(2-Aminoethyl)piperazine, CAS: 140-31-8, stock: 2.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₅N₃.

1-(2-Bromo-5-chlorophenyl)-4-methylpiperazine, CAS: 1261940-25-3, stock: 5.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄N₂ClBr.

1-(2-Bromo-5-chlorophenyl)piperazine, CAS: 1538703-71-7, stock: 8.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂BrClN₂.

1-(2-Bromobenzyl)piperazine Hydrochloride, CAS: 1063613-12-6, stock: 4.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅N₂Br  •  HCl.

1-(2-Bromophenyl)carbonyl-4-methylpiperazine, CAS: 331845-66-0, stock: 4.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅BrN₂O.

1-(2-Bromophenyl)piperazine, CAS: 1011-13-8, stock: 8.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N₂Br.

1-(2-Butyl)piperazine, CAS: 34581-21-0, stock: 5.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₈N₂.

1-(2-Chloro-4-fluorobenzyl)piperazine, CAS: 118630-33-4, stock: 8.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄N₂FCl.

1-(2-Chloro-4-nitrophenyl)piperazine, CAS: 114878-60-3, stock: 8.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₃O₂Cl.

1-(2-Chloro-6-fluorobenzoyl)piperazine, CAS: 1016491-13-6, stock: 2.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂N₂OFCl.

1-(2-Chloro-6-fluorobenzyl)piperazine, CAS: 215655-20-2, stock: 7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄N₂FCl.

1-(2-Chloroacetyl)-4-methylpiperazine hydrochloride, CAS: 42951-91-7, stock: 8.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₄Cl₂N₂O.

1-(2-Chlorobenzenesulfonyl)piperazine Hydrochloride, CAS: 1049791-62-9, stock: 9.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N₂O₂SCl  •  HCl.

1-(2-Chlorobenzyl)piperazine, CAS: 17532-19-3, stock: 9.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅ClN₂.

1-(2-Chloroethyl)-4-methylpiperazine Hydrochloride, CAS: 126055-32-1, stock: 2.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₅N₂Cl • HCl.

1-(2-Chlorophenyl)piperazine, CAS: 39512-50-0, stock: 8.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃ClN₂.

1-(2-Cyanophenyl)piperazine, CAS: 111373-03-6, stock: 8.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃N₃.

1-(2-Diallylaminoethyl)piperazine, CAS: 199475-35-9, stock: 7.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₃N₃.

1-(2-Diethylaminoethyl)piperazine, CAS: 4038-92-0, stock: 3.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₃N₃.

1-(2-Diisopropylaminoethyl)piperazine, CAS: 59955-93-0, stock: 3.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₇N₃.

1-(2-Dimethylaminoethyl)-4-methylpiperazine, CAS: 104-19-8, stock: 10g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₂₁N₃.

1-(2-Ethoxy-phenyl)-piperazine Dihydrochloride, CAS: 164009-65-8, stock: 3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈N₂O • 2(HCl).

1-(2-Ethoxyethyl)piperazine, CAS: 13484-38-3, stock: 7.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₈N₂O.

1-(2-Ethoxyphenyl)piperazine, CAS: 13339-01-0, stock: 7.5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈N₂O.

1-(2-Fluoro-3-methoxyphenyl)piperazine, CAS: 1121613-59-9, stock: 2.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅N₂OF.

1-(2-Fluoro-4-nitrophenyl)-4-methylpiperazine, CAS: 221198-29-4, stock: 6.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄FN₃O₂.

1-(2-Fluoro-4-nitrophenyl)piperazine, CAS: 154590-33-7, stock: 9.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂FN₃O₂.

1-(2-Fluoro-6-methoxyphenyl)piperazine, CAS: 113028-78-7, stock: 1.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅N₂OF.

1-(2-Fluorobenzyl)piperazine, CAS: 435345-41-8, stock: 6.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅FN₂.

1-(2-Fluorobenzyl)piperazine, CAS: 89292-78-4, stock: 9.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅N₂F.

1-(2-Fluoroethyl)piperazine Dihydrochloride, CAS: 1089279-64-0, stock: 7.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₅Cl₂FN₂.

1-(2-Fluorophenyl)-piperazine Dihydrochloride, CAS: 76835-09-1, stock: 1.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅Cl₂FN₂.

1-(2-Fluorophenyl)piperazine, CAS: 1011-15-0, stock: 8.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃FN₂.

1-(2-Fluorophenyl)piperazine Hydrochloride, CAS: /, stock: 7.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃FN₂ •xHCl.

1-(2-Fluorophenyl)piperazine Hydrochloride, CAS: 1011-16-1, stock: 3.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄ClFN₂.

1-(2-Furoyl)piperazine Hydrochloride, CAS: 60548-09-6, stock: 8.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂O₂ • HCl.

1-(2-Furylmethyl)piperazine, CAS: 59037-70-6, stock: 8.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄N₂O.

1-(2-Furylmethyl)piperazine Dihydrochloride, CAS: 1185304-05-5, stock: 2.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄N₂O • 2HCl.

1-(2-Hydroxyethyl)-4-isopropyl-piperazine, CAS: 103069-50-7, stock: 4.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₂₀N₂O.

1-(2-Hydroxyethyl)-4-methylpiperazine, CAS: 5464-12-0, stock: 6.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₆N₂O.

1-(2-Hydroxyphenyl)-4-(tert-butoxycarbonyl)piperazine, CAS: 313657-51-1, stock: 6.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂N₂O₃.

1-(2-Hydroxyphenyl)piperazine Dihydrobromide, CAS: 58260-69-8, stock: 7.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₂O  • 2HBr.

1-(2-Iodobenzoyl)piperazine Hydrochloride, CAS: 1193387-17-5, stock: 9.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃N₂OI  •  HCl.

1-(2-Methoxy-benzyl)-piperazine Hydrochloride, CAS: 1185292-94-7, stock: 2.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈N₂O • HCl.

1-(2-Methoxybenzoyl)piperazine, CAS: 100939-88-6, stock: 3.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆N₂O₂.

1-(2-Methoxybenzyl)piperazine, CAS: 55037-81-5, stock: 2.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈N₂O.

1-(2-Methoxybenzyl)piperazine Dihydrochloride, CAS: 113698-78-5, stock: 9.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₀Cl₂N₂O.

1-(2-Methoxyethyl)-2,6-dimethylpiperazine, CAS: 1017120-41-0, stock: 8.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₂₀N₂O.

1-(2-Methoxyethyl)-2-methylpiperazine, CAS: 1225603-87-1, stock: 3.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₈N₂O.

1-(2-Methoxyethyl)piperazine, CAS: 13484-40-7, stock: 1.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₆N₂O.

1-(2-Methoxyphenethyl)piperazine, CAS: 6722-54-9, stock: 3.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₀N₂O.

1-(2-Methoxyphenyl)piperazine, CAS: 35386-24-4, stock: 8.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₂O.

1-(2-Methoxyphenyl)piperazine Hydrobromide, CAS: 100939-96-6, stock: 1.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₂O  • HBr.

1-(2-Methoxyphenyl)piperazine Hydrochloride, CAS: 5464-78-8, stock: 6.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₇ClN₂O.

1-(2-Methoxyphenyl)piperazine-d8 Hydrochloride, CAS: 1185090-82-7, stock: 9.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉D₈ClN₂O.

1-(2-Methylbenzoyl)piperazine, CAS: 775579-10-7, stock: 9.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆N₂O.

1-(2-Methylbenzyl)piperazine, CAS: 5321-47-1, stock: 8.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈N₂.

1-(2-Methylfuran-3-carbonyl)piperazine Hydrochloride, CAS: 1193388-14-5, stock: 7.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₂O₂ • HCl.

1-(2-Methylphenyl)piperazine, CAS: 39512-51-1, stock: 5.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₂.

1-(2-Nitrophenyl)piperazine, CAS: 59084-06-9, stock: 5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N₃O₂.

1-(2-Nitrophenyl)piperazine Hydrochloride, CAS: 08/12/6270, stock: 8.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N₃O₂ • HCl.

1-(2-Pentyl)piperazine, CAS: 82499-96-5, stock: 2.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₂₀N₂.

1-(2-Phenoxyethyl)piperazine, CAS: 13484-37-2, stock: 9.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈N₂O.

1-(2-Phenylmethoxyphenyl)piperazine Dihydrochloride, CAS: 1187930-93-3, stock: 5.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀N₂O • 2HCl.

1-(2-Piperidin-1-ylethyl)piperazine, CAS: 22763-65-1, stock: 4.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₃N₃.

1-(2-Propoxyethyl)piperazine, CAS: 741667-07-2, stock: 6.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₂₀N₂O.

1-(2-Pyridyl)piperazine, CAS: 34803-66-2, stock: 1.5g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃N₃.

1-(2-Pyridyl)piperazine Monohydrochloride, CAS: 129394-11-2, stock: 5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃N₃.HCl.

1-(2-Tetrahydrofuroyl)piperazine Hydrobromide, CAS: 63590-62-5, stock: 5.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₇BrN₂O₂.

1-(2-Thiophen-2-yl-ethyl)piperazine, CAS: 461046-73-1, stock: 8.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆N₂S.

1-(3,3-Diphenylpropionyl)piperazine Hydrochloride, CAS: 856841-75-3, stock: 9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₃ClN₂O.

1-(3,4,5-Trimethoxybenzyl)piperazine, CAS: 52146-35-7, stock: 9.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₂N₂O₃.

1-(3,4-Dichlorobenzyl)piperazine, CAS: 55513-17-2, stock: 3.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄Cl₂N₂.

1-(3,4-Dichlorophenyl)piperazine, CAS: 57260-67-0, stock: 3.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂Cl₂N₂.

1-(3,4-Dichlorophenyl)piperazine Hydrochloride, CAS: 88138-89-0, stock: 4.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂Cl₂N₂•HCl.

1-(3,4-Difluorobenzoyl)piperazine Hydrochloride, CAS: 1171078-91-3, stock: 1.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂N₂OF₂ • HCl.

1-(3,4-Difluorophenyl)piperazine Hydrochloride, CAS: 853745-58-1, stock: 3.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₂F₂ • HCl.

1-(3,4-Dimethoxybenzoyl)piperazine Hydrochloride, CAS: 119049-61-5, stock: 4.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈N₂O₃ • HCl.

1-(3,4-Dimethylphenyl)piperazine, CAS: 1014-05-7, stock: 9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈N₂.

1-(3,4-Methylenedioxybenzyl)-4-(5-hydroxy-2-pyrimidyl)piperazine, CAS: 50602-51-2, stock: 5.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈N₄O₃.

1-(3,5,6-Trifluoropyridin-2-yl)piperazine, CAS: 1226516-20-6, stock: 8.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀N₃F₃.

1-(3,5-bis-Trifluoromethylphenyl)piperazine, CAS: 16172-96-6, stock: 5.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂N₂F₆.

1-(3,5-Dibromophenyl)piperazine, CAS: 1121610-24-9, stock: 8.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂Br₂N₂.

1-(3,5-Dichlorobenzoyl)piperazine Hydrochloride, CAS: 1134449-64-1, stock: 9.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂N₂OCl₂ • HCl.

1-(3,5-Dichlorophenyl)piperazine, CAS: 55827-50-4, stock: 1.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₂Cl₂.

1-(3,5-Dichloropyridin-2-yl)piperazine, CAS: 87394-60-3, stock: 7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁N₃Cl₂.

1-(3,5-Dichloropyridin-4-yl)piperazine, CAS: 175277-80-2, stock: 8.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁N₃Cl₂.

1-(3,5-Dimethoxybenzoyl)piperazine Hydrochloride, CAS: 119049-62-6, stock: 9.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈N₂O₃ • HCl.

1-(3,5-Dimethylphenyl)piperazine, CAS: 105907-65-1, stock: 1.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈N₂.

1-(3-Bromo-5-methylpyridin-2-yl)-4-ethylpiperazine, CAS: 1187386-39-5, stock: 1.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈N₃Br.

1-(3-Bromo-5-methylpyridin-2-yl)-4-propylpiperazine hydrochloride, CAS: 1187386-03-3, stock: 1.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₁BrClN₃.

1-(3-Bromo-5-methylpyridin-2-yl)piperazine, CAS: 1187386-35-1, stock: 3.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄BrN₃.

1-(3-Bromophenyl)piperazine, CAS: 31197-30-5, stock: 5.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N₂Br.

1-(3-Bromophenyl)piperazine Hydrochloride, CAS: 796856-45-6, stock: 4.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄BrClN₂.

1-(3-Bromopropyl)-4-(3-chlorophenyl)piperazine, CAS: 142944-48-7, stock: 5.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈BrClN₂.

1-(3-Carboxy-2-pyridyl)-4-methyl-2-phenylpiperazine, CAS: 61338-13-4, stock: 6.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉N₃O₂.

1-(3-Chloro-2-methylpropyl)-4-methylpiperazine Dihydrochloride, CAS: 102449-98-9, stock: 5.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₂₁Cl₃N₂.

1-(3-Chlorobenzoyl)piperazine, CAS: 100939-90-0, stock: 2.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃N₂OCl.

1-(3-Chlorobenzoyl)piperazine Hydrochloride, CAS: 100940-00-9, stock: 8.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃N₂OCl •  HCl.

1-(3-Chlorobenzyl)piperazine, CAS: 23145-91-7, stock: 5.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅ClN₂.

1-(3-Chlorophenyl)-4-(3-chloropropyl)piperazine Hydrochloride, CAS: 52605-52-4, stock: 2.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₉Cl₃N₂.

1-(3-Chlorophenyl)-4-propylpiperazine, CAS: 144146-59-8, stock: 3.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₉ClN₂.

1-(3-Chlorophenyl)piperazine Dihydrochloride, CAS: 51639-49-7, stock: 6.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N₂Cl • 2(HCl).

1-(3-Chloropropyl)-4-methylpiperazine, CAS: 104-16-5, stock: 3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₇ClN₂.

1-(3-Chloropropyl)-4-methylpiperazine Dihydrochloride, CAS: 2031-23-4, stock: 9.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₉Cl₃N₂.

1-(3-Chloropropyl)-4-methylpiperazine Dihydrochloride, CAS: 2031-23-4, stock: 4.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₉Cl₃N₂.

1-(3-Chloropyridin-2-yl)piperazine, CAS: 87394-55-6, stock: 8.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂ClN₃.

1-(3-Chloropyridin-2-yl)piperazine Dihydrochloride, CAS: 1193389-39-7, stock: 7.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₃Cl • 2[HCl].

1-(3-Cyano-2-pyridyl)-4-methyl-2-phenylpiperazine, CAS: 61337-88-0, stock: 9.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈N₄.

1-(3-Cyano-2-pyridyl)-4-methyl-2-phenylpiperazine-d4, CAS: /, stock: 5.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₄D₄N₄.

1-(3-Cyanobenzyl)piperazine, CAS: 203047-38-5, stock: 3.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅N₃.

1-(3-Cyanophenyl)piperazine, CAS: 178928-58-0, stock: 8.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃N₃.

1-(3-Cyclohexylprop-1-yl)piperazine, CAS: 800372-97-8, stock: 8.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₆N₂.

1-(3-Diethylaminopropyl)piperazine, CAS: 22764-55-2, stock: 7.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₅N₃.

1-(3-Ethoxy-4-nitrophenyl)piperazine, CAS: 1089280-28-3, stock: 5.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇N₃O₃.

1-(3-Fluoro-4-methylbenzoyl)piperazine Hydrochloride, CAS: 1181457-89-5, stock: 5.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅N₂OF • HCl.

1-(3-Fluorobenzoyl)piperazine Hydrochloride, CAS: 1187890-39-6, stock: 9.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃N₂OF • HCl.

1-(3-Fluorobenzyl)piperazine, CAS: 55513-19-4, stock: 2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅FN₂.

1-(3-Fluorophenyl)-4-methylpiperazine, CAS: 218940-66-0, stock: 8.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅FN₂.

1-(3-Fluorophenyl)-piperazine, CAS: 3801-89-6, stock: 2.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃FN₂.

(DL-Phenylglycyl)-piperacilloic Acid, CAS: /, stock: 1.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₉N₅O₈S.

1-(3-Hydroxy-phenyl)-piperazine-4-carboxylic acid tert-butyl ester, CAS: 198627-86-0, stock: 2.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂N₂O₃.

1-(3-Hydroxyphenyl)piperazine, CAS: 59817-32-2, stock: 3.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₂O.

(S)-α-[[(4-Ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino]benzeneacetic Acid, CAS: 122645-11-8, stock: 6.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₇N₃O₅.

1-(3-Hydroxypropyl)piperazine, CAS: 5317-32-8, stock: 3.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₆N₂O.

1-(3-Methoxy-4-methylbenzoyl)piperazine Hydrochloride, CAS: 1171557-04-2, stock: 5.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈N₂O₂ • HCl.

1-(3-Methoxy-4-nitrophenyl)-4-methylpiperazine, CAS: 761440-26-0, stock: 2.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇N₃O₃.

1-(3-Methoxy-4-nitrophenyl)piperazine, CAS: 121278-37-3, stock: 6.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅N₃O₃.

1-(3-Methoxybenzyl)piperazine Dihydrochloride, CAS: 113698-79-6, stock: 4.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈N₂O • 2[HCl].

1-(3-Methoxyphenyl)piperazine, CAS: 16015-71-7, stock: 9.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₂O.

1-(3-Methoxyphenyl)piperazine Dihydrochloride, CAS: 6968-76-9, stock: 8.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₂O • 2(HCl).

DL-Phenylglycyl 2-epi-Thoazolino Piperacilloic Acid, CAS: /, stock: 4.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₉N₅O₈S.

1-(3-Methoxypropyl)piperazine, CAS: 88708-40-1, stock: 1.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₈N₂O.

1-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)piperazine, CAS: 401566-79-8, stock: 2.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈N₄.

Monodecarboxy (DL-Phenylglycyl) Piperacilloic Acid, CAS: /, stock: 2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₉N₅O₆S.

1-(3-Methyl-2-pyridinyl)piperazine, CAS: 104396-10-3, stock: 8.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅N₃.

1-(3-Methyl-benzoyl)-piperazine, CAS: 100939-91-1, stock: 1.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆N₂O.

1-(3-Methyl-pyridin-2-ylmethyl)piperazine Dihydrochloride, CAS: 1185299-95-9, stock: 4.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₇N₃ • 2HCl.

1-(3-Methylbenzyl)piperazine, CAS: 5321-48-2, stock: 4.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈N₂.

1-(3-Methylbenzyl)piperazine-d8, CAS: 1189927-23-8, stock: 1.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₀D₈N₂.

1-(3-Methylcyclohexyl)piperazine Dihydrochloride, CAS: 1609408-92-5, stock: 7.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₂N₂ • 2[HCl].

1-(3-Methylphenyl)piperazine, CAS: 41186-03-2, stock: 4.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₂.

1-(3-Methylpyridin-4-yl)piperazine, CAS: 112940-51-9, stock: 4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅N₃.

1-(3-Nitrobenzyl)piperazine Dihydrochloride, CAS: 827614-55-1, stock: 3.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅N₃O₂ • 2(HCl).

1-(3-Nitrobenzyl)piperazine Hydrochloride, CAS: 1458615-92-3, stock: 5.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅N₃O₂ •  HCl.

1-(3-Nitrophenyl)piperazine, CAS: 54054-85-2, stock: 4.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N₃O₂.

Piperacillinyl-(4-amino-2-ph-butyryl)-6-aminopenicillanic Acid, CAS: /, stock: 1.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₄₈N₈O₁₀S₂.

1-(3-nitrophenyl)piperazine hydrochloride, CAS: 294210-79-0, stock: 8.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N₃O₂ • HCl.

1-(3-Pentyl)-piperazine, CAS: 373356-51-5, stock: 5.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₂₀N₂.

1-(3-Phenoxybenzyl)piperazine, CAS: 114010-96-7, stock: 9.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀N₂O.

1-(3-Phenylpropyl)piperazine, CAS: 55455-92-0, stock: 1.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₀N₂.

1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)piperazine, CAS: 1245505-23-0, stock: 3.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₇BN₂O₂.

1-(4-Amino-3-methoxyphenyl)-4-methylpiperazine, CAS: 122833-04-9, stock: 3.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₉N₃O.

1-(4-Amino-phenyl)-piperazine Trihydrochloride, CAS: 125421-99-0, stock: 7.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅N₃ • 3(HCl).

1-(4-Aminophenyl)piperazine, CAS: 67455-41-8, stock: 8.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅N₃.

1-(4-Benzyloxy-3-chlorophenyl)piperazine, CAS: 800371-67-9, stock: 7.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉ClN₂O.

1-(4-Benzyloxy-phenyl)-piperazine Dihydrochloride, CAS: 1187929-01-6, stock: 1.2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀N₂O  • 2HCl.

1-(4-Bromo-2,5-dimethoxybenzyl)piperazine, CAS: 1094424-37-9, stock: 9.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₉BrN₂O₂.

1-(4-Bromo-2,5-dimethoxybenzyl)piperazine-d8, CAS: 1346600-96-1, stock: 5.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₁D₈BrN₂O₂.

1-(4-Bromo-2-methylbenzoyl)piperazine, CAS: 1156842-50-0, stock: 5.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅N₂OBr.

1-(4-Bromo-2-methylphenyl)piperazine, CAS: 501903-60-2, stock: 1.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅N₂Br.

1-(4-Bromo-3-chlorophenyl)-4-ethylpiperazine, CAS: 1426958-32-8, stock: 4.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆N₂ClBr.

1-(4-Bromo-3-chlorophenyl)-4-methylpiperazine, CAS: 1426958-37-3, stock: 3.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄BrClN₂.

1-(4-Bromobenzoyl)-4-methylpiperazine, CAS: 349395-87-5, stock: 8.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅N₂OBr.

1-(4-Bromophenyl)-4-(ethylsulfonyl)piperazine, CAS: 1221658-67-8, stock: 6.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇N₂O₂SBr.

1-(4-Bromophenyl)-4-isopropylpiperazine, CAS: 844431-60-3, stock: 6.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₉N₂Br.

1-(4-Bromophenyl)-4-methylpiperazine, CAS: 130307-08-3, stock: 5.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅N₂Br.

1-(4-Bromophenyl)piperazine, CAS: 66698-28-0, stock: 9.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N₂Br.₂[HCl].

1-(4-Bromophenyl)piperazine Hydrochloride, CAS: 68104-62-1, stock: 7.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N₂Br • HCl.

1-(4-Bromophenylsulfonyl)-4-butylpiperazine, CAS: 1199773-16-4, stock: 8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₁BrN₂O₂S.

1-(4-Bromophenylsulfonyl)-4-ethylpiperazine, CAS: 385404-09-1, stock: 2.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇BrN₂O₂S.

1-(4-Bromophenylsulfonyl)-4-isobutylpiperazine, CAS: 1187385-78-9, stock: 1.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₁BrN₂O₂S.

1-(4-Bromophenylsulfonyl)-4-methylpiperazine, CAS: 837-12-7, stock: 2.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅BrN₂O₂S.

1-(4-Bromophenylsulfonyl)-4-propylpiperazine, CAS: 888181-08-6, stock: 4.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₉BrN₂O₂S.

1-(4-Bromophenylsulfonyl)piperazine, CAS: 179334-20-4, stock: 2.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃BrN₂O₂S.

1-(4-Chloro-1H-pyrrole-2-carbonyl)piperazine, CAS: 1042557-52-7, stock: 1.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₃OCl.

1-(4-Chloro-2-fluorobenzoyl)piperazine Hydrochloride, CAS: 1240529-28-5, stock: 7.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂N₂OFCl • HCl.

1-(4-Chloro-benzenesulfonyl)-piperazine, CAS: 16017-53-1, stock: 1.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃ClN₂O₂S.

1-(4-Chloro-pyridin-2-yl)-piperazine Dihydrochloride, CAS: 1187932-16-6, stock: 4.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₃Cl • 2HCl.

1-(4-Chlorobenzoyl)piperazine, CAS: 54042-47-6, stock: 8.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃ClN₂O.

1-(4-Chlorobenzyl)piperazine, CAS: 23145-88-2, stock: 5.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅ClN₂.

1-(4-Chlorophenyl)piperazine, CAS: 38212-33-8, stock: 4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃ClN₂.

1-(4-Chlorophenyl)piperazine Dihydrochloride, CAS: 38869-46-4, stock: 6.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅Cl₃N₂.

1-(4-Chlorophenyl)piperazine Hydrochloride, CAS: 13078-12-1, stock: 4.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄Cl₂N₂.

1-(4-Cyanobenzyl)piperazine, CAS: 89292-70-6, stock: 6.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅N₃.

1-(4-Cyanophenyl)piperazine, CAS: 68104-63-2, stock: 1.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃N₃.

1-(4-Ethoxyphenyl)piperazine, CAS: 46415-29-6, stock: 6.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈N₂O.

1-(4-Ethylbenzoyl)piperazine Hydrochloride, CAS: 1171550-67-6, stock: 4.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈N₂O • HCl.

1-(4-Fluoro-2-methoxyphenyl)piperazine, CAS: 102392-11-0, stock: 8.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅N₂OF.

1-(4-Fluoro-2-nitrophenyl)-4-methylpiperazine, CAS: 432531-43-6, stock: 6.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄FN₃O₂.

1-(4-Fluoro-2-nitrophenyl)piperazine, CAS: 243128-46-3, stock: 2.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂FN₃O₂.

1-(4-Fluoro-3-nitrophenyl)-4-methylpiperazine, CAS: 1216614-11-7, stock: 8.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄N₃O₂F.

1-(4-Fluoro-benzenesulfonyl)-piperazine, CAS: 27106-49-6, stock: 2.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃FN₂O₂S.

1-(4-Fluorobenzyl)-4-(2-hydroxyethyl)piperazine, CAS: 174561-11-6, stock: 5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₉N₂OF.

1-(4-Fluorobenzyl)homopiperazine Dihydrochloride, CAS: 199672-23-6, stock: 7.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇N₂F • 2(HCl).

1-(4-Fluorobenzyl)homopiperazine Dihydrochloride Hydrate, CAS: 1049733-90-5, stock: 4.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇N₂F • 2[HCl] • H  ₂O.

1-(4-Fluorobenzyl)piperazine, CAS: 70931-28-1, stock: 5.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅FN₂.

1-(4-Fluorophenyl)piperazine, CAS: 2252-63-3, stock: 2.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃FN₂.

1-(4-Fluorophenyl)piperazine Dihydrochloride, CAS: 64090-19-3, stock: 7.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅Cl₂FN₂.

1-(4-fluorophenyl)piperazine hydrochloride, CAS: 16141-90-5, stock: 8.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N₂F • HCl.

1-(4-Hydroxybutyl)-4-methylpiperazine, CAS: 56323-03-6, stock: 8.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₂₀N₂O.

1-(4-Hydroxyphenyl)piperazine, CAS: 56621-48-8, stock: 8.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₂O.

1-(4-Iodo-phenyl)-piperazine, CAS: 96530-59-5, stock: 7.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N₂I.

1-(4-Iodobenzoyl)-4-methylpiperazine, CAS: 102294-90-6, stock: 6.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅N₂OI.

1-(4-Iodobenzyl)-4-methylpiperazine, CAS: 102294-97-3, stock: 1.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇N₂I.

1-(4-Iodophenyl)-4-methylpiperazine, CAS: 1125409-95-1, stock: 1.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅IN₂.

1-(4-Isopropyl-benzoyl)piperazine, CAS: 926258-12-0, stock: 1.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀N₂O.

1-(4-Methoxybenzenesulfonyl)piperazine Hydrochloride, CAS: 1044761-18-3, stock: 8.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₂O₃S • HCl.

1-(4-Methoxybenzoyl)-piperazine, CAS: 94747-49-6, stock: 5.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆N₂O₂.

1-(4-Methoxybenzoyl)piperazine Hydrochloride, CAS: 1030288-85-7, stock: 4.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆N₂O₂ •  HCl.

1-(4-Methoxybenzyl)piperazine, CAS: 21867-69-6, stock: 4.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈N₂O.

1-(4-Methoxybenzyl)piperazine Hydrochloride, CAS: 109188-09-2, stock: 2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈N₂O  •  HCl.

1-(4-Methoxyphenyl)piperazine, CAS: 38212-30-5, stock: 8.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₂O.

1-(4-Methylbenzoyl)piperazine, CAS: 111752-26-2, stock: 8.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆N₂O.

1-(4-Methyloxy-phenyl)-4-(4-nitro-phenyl)-piperazine, CAS: 74852-61-2, stock: 9.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉N₃O₃.

1-(4-Methylphenyl)piperazine, CAS: 39593-08-3, stock: 3.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₂.

1-(4-Methylphenyl)piperazine Hydrochloride, CAS: 13078-14-3, stock: 8.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₂ •  2(HCl).

1-(4-Methylpyridin-2-yl)piperazine, CAS: 34803-67-3, stock: 1.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅N₃.

1-(4-Methylsulfonyl-2-nitrophenyl)piperazine, CAS: 610275-77-9, stock: 2.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅N₃O₄S.

1-(4-Nitrobenzoyl)piperazine, CAS: 72141-41-4, stock: 4.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃N₃O₃.

1-(4-Nitrophenyl)-4-propylpiperazine, CAS: 1030627-12-3, stock: 8.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₉N₃O₂.

1-(4-Nitrophenyl)piperazine Hydrochloride, CAS: 260252-87-7, stock: 8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N₃O₂ • HCl.

1-(4-Nitrophenylsulfonyl)piperazine Hydrochloride, CAS: 1049751-39-4, stock: 5.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N₃O₄S • HCl.

1-(4-O-Methoxymethyl-4-hydroxyphenyl)-4-(4-nitrophenyl)piperazine, CAS: 1246819-65-7, stock: 4.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₁N₃O₄.

1-(4-O-Methoxymethyl-4-hydroxyphenyl)-4-(4-nitrophenyl)piperazine-d4, CAS: 1246819-68-0, stock: 5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇D₄N₃O₄.

1-(4-Phenyl-1,3-thiazol-2-yl)piperazine, CAS: 69389-14-6, stock: 1.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅N₃S.

1-(4-Phenyl-1,3-thiazol-2-yl)piperazine-d8, CAS: /, stock: 5.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₇D₈N₃S.

1-(4-Propylbenzenesulfonyl)piperazine Hydrochloride, CAS: 1181458-47-8, stock: 5.1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₀N₂O₂S • HCl.

1-(4-Pyridinylmethyl)-piperazine, CAS: 62089-74-1, stock: 5.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅N₃.

1-(4-Pyridyl)piperazine, CAS: 1008-91-9, stock: 1.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃N₃.

1-(4-tert-Butylbenzoyl)piperazine, CAS: 118630-34-5, stock: 6.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂N₂O.

1-(4-tert-Butylbenzyl)piperazine, CAS: 956-61-6, stock: 2.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₄N₂.

1-(4-Trifluoromethylbenzyl)piperazine, CAS: 107890-32-4, stock: 4.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅F₃N₂.

1-(4-Trifluoromethylphenyl)piperazine, CAS: 30459-17-7, stock: 9.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃N₂F₃.

1-(5-Bromo-3-nitropyridin-2-yl)piperazine, CAS: 1203499-08-4, stock: 6.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁N₄O₂Br.

1-(5-Bromo-6-methylpyridin-2-yl)-4-ethylpiperazine, CAS: 1289270-94-5, stock: 9.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈BrN₃.

1-(5-Bromo-6-methylpyridin-2-yl)-4-methylpiperazine, CAS: 1454301-28-0, stock: 6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆BrN₃.

1-(5-Bromopyridin-2-yl)piperazine Dihydrochloride, CAS: 1170221-91-6, stock: 5.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₃Br • 2[HCl].

1-(5-Bromopyridin-3-yl)-4-methylpiperazine, CAS: 1130759-48-6, stock: 4.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₃Br.

1-(5-Chloro-2-fluorobenzoyl)piperazine Hydrochloride, CAS: 1172407-04-3, stock: 7.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂N₂OFCl • HCl.

1-(5-Chloro-2-methoxy-phenyl)-piperazinex Hydrochloride, CAS: 99857-72-4, stock: 9.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆Cl₂N₂O.